Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1050.Time spend outdoors in summer,45269,0.0353272584761992,0.0235062659162126,-0.0107450227195774,0.0813995396719758,0.132875196560876
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1060.Time spent outdoors in winter,39521,-0.00739073754741792,0.0264049647701919,-0.059144468496994,0.0443629934021582,0.779556043986645
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1070.Time spent watching television (TV),47580,0.130371274904979,0.0236294010074003,0.084057648930474,0.176684900879483,3.45971723788173e-08
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1080.Time spent using computer,39468,-0.113699958191332,0.0242296730622877,-0.161190117393416,-0.0662097989892482,2.70669907545336e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X1090.Time spent driving,34273,0.018493487470558,0.0265356340211903,-0.033516355210975,0.070503330152091,0.485851141210837
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1160.Sleep duration,50132,-0.0329790611121299,0.0214294593556566,-0.0749808014492167,0.00902267922495699,0.123820598984146
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16773,-0.0132380704425942,0.00977780819396848,-0.0324025745027724,0.00592643361758399,0.175789936465998
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16773,0.00817281022472718,0.00953421244391902,-0.0105142461653541,0.0268598666148085,0.391341791273963
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16773,0.0100238820849001,0.0108985877160212,-0.0113373498385013,0.0313851140083016,0.357721161830017
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16773,0.000976542435903372,0.0111506748281747,-0.020878780227319,0.0228318650991257,0.930213944823781
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16773,0.0135229658988399,0.0113618761439822,-0.00874631134336517,0.0357922431410451,0.233982545941575
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16773,0.00953936401192312,0.0240809719890301,-0.037659341086576,0.0567380691104222,0.692009006998116
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16773,-0.0346157286311706,0.0251857081717995,-0.0839797166478976,0.0147482593855564,0.169329861375882
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16773,0.0231467395548436,0.017118030002037,-0.0104045992491489,0.0566980783588361,0.176334458885669
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16773,0.00123570019503842,0.0125643821338236,-0.0233904887872559,0.0258618891773327,0.921655981505742
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16773,-0.00344048777737531,0.00860896850323359,-0.0203140660437132,0.0134330904889625,0.689426817101532
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16773,-0.00343634172285468,0.0124746241105768,-0.0278866049795852,0.0210139215338759,0.782961213939312
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16773,-0.00808905887382664,0.00696806233469149,-0.021746461049822,0.00556834330216869,0.245708716872984
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16773,-0.00505382723254123,0.0090459902608899,-0.0227839681438854,0.012676313678803,0.576386584834422
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16773,0.00348494288072222,0.0133955917821484,-0.0227704170122887,0.0297403027737331,0.79474667884501
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16773,-0.00932307484558766,0.0126777099273789,-0.0341713863032504,0.0155252366120751,0.462111641345027
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16773,0.0226474678657045,0.0169489824877867,-0.0105725378103574,0.0558674735417664,0.181497475122635
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16773,-0.0126047197842839,0.0160228019440029,-0.0440094115945295,0.0187999720259616,0.431483921509238
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16773,-0.00931235683582981,0.00979706214916836,-0.0285145986481998,0.00988988497654018,0.341859039568714
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16773,-0.00849645383232833,0.00932171048626065,-0.0267670063853992,0.00977409872074254,0.362061213288629
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16773,0.00764247286019578,0.0115845464836988,-0.0150632382478539,0.0303481839682455,0.509447257371934
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120040.Fatigue severity over the past week,16784,0.0887444318338902,0.0383945042152681,0.0134912035719648,0.163997660095816,0.0208237327646361
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,16784,0.0534250257852089,0.0381723185139805,-0.0213927185021929,0.128242770072611,0.161659099652279
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,16784,0.0612342344176634,0.0412948248046807,-0.0197036221995108,0.142172091034838,0.138131752615453
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120098.Mobility problems today,16793,0.0487415727020485,0.0447803441285664,-0.0390279017899416,0.136511047194039,0.276408122842947
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120099.Self-care problems today,16793,0.00515743401277178,0.0692586925339725,-0.130589603353814,0.140904471379358,0.940640295679995
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120100.Problems doing usual activities,16793,0.0267590218776311,0.0428880405698857,-0.0573015376393448,0.110819581394607,0.532683775537768
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120101.Pain or discomfort today,16793,0.0112199350730664,0.0383877682648948,-0.0640200907261275,0.0864599608722603,0.770076996780338
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120102.Anxiety or depression today,16793,0.0955535026776398,0.0465147581453641,0.00438457671272618,0.186722428642553,0.039965793861606
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120103.Scale to indicate how health is today,16740,-0.00264601090905253,0.00302457722942648,-0.00857418227872843,0.00328216046062337,0.381675372405646
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16754,0.0689112369854958,0.0470427523340332,-0.0232925575892093,0.161115031560201,0.142976793202266
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16728,0.046787011753906,0.0483508710443403,-0.0479806954930011,0.141554719000813,0.33323018941156
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16763,0.030533915648243,0.0382041623390428,-0.0443462425362808,0.105414073832767,0.424168349263208
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16762,0.0500879392487675,0.0389549445560207,-0.026263752081033,0.126439630578568,0.19853359287738
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16771,0.0853336089567921,0.050499788935285,-0.0136459773563666,0.184313195269951,0.0910883684763008
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,16727,0.0845324894993654,0.0508090566374703,-0.0150532615100764,0.184118240508807,0.0961853936118893
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,16770,0.0336296521857995,0.050813534281884,-0.065964875006693,0.133224179378292,0.508092675389358
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16754,0.103973389986974,0.0739513055724679,-0.0409711689350627,0.248917948909012,0.159751303375426
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16680,0.0647740644179086,0.101533309500485,-0.134231222203041,0.263779351038859,0.52350929067873
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11682,0.028280846852866,0.0518835714986461,-0.0734109532844805,0.129972646990212,0.585706933226626
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45351,0.139181969610561,0.0512727127366435,0.0386874526467399,0.239676486574383,0.00663924411013635
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42326,0.0349456631263194,0.0316139738748039,-0.0270177256682962,0.0969090519209351,0.268998392523694
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1289.Cooked vegetable intake,48694,-0.168753504038761,0.0224778491117919,-0.212810088297873,-0.124696919779649,6.12710253058296e-14
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47385,-0.194496266219791,0.0237647362888156,-0.24107514934587,-0.147917383093712,2.80787963069012e-16
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1309.Fresh fruit intake,48597,-0.237615924921174,0.0235012588432902,-0.283678392254023,-0.191553457588325,5.22766818198283e-24
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1319.Dried fruit intake,45888,-0.222815841205424,0.0242818861369435,-0.270408338033833,-0.175223344377014,4.64496712812108e-20
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X134.Number of self-reported cancers,50561,0.0763447389135371,0.0419782302755138,-0.00593259242647004,0.158622070253544,0.0689670123968986
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,50562,0.0467592524564696,0.0224004464833929,0.00285437734901962,0.0906641275639196,0.0368547275846983
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X136.Number of operations, self-reported",50562,-0.00145464109497945,0.0220333556010597,-0.0446400180730565,0.0417307358830976,0.947362201234274
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X137.Number of treatments or medications taken,50562,0.00131531015708938,0.0218343320374243,-0.0414799806362623,0.044110600950441,0.951964361717498
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1438.Bread intake,49087,0.00264334605642694,0.001838147736075,-0.000959423506280066,0.00624611561913395,0.150426599017252
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1458.Cereal intake,47994,-0.135282164464697,0.0222772987829981,-0.178945670079373,-0.0916186588500205,1.26761488975021e-09
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1488.Tea intake,48793,-0.00510810254430169,0.00175397794845761,-0.0085458993232786,-0.00167030576532478,0.00358945328673596
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1498.Coffee intake,46588,-0.016611502290405,0.0223615960999912,-0.0604402306463878,0.0272172260655777,0.45757108517177
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X1528.Water intake,46752,-0.145932699423938,0.022795924855398,-0.190612712140518,-0.101252686707358,1.55108238558335e-10
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1568.Average weekly red wine intake,34416,-0.15380984962798,0.026280406287509,-0.205319445951498,-0.102300253304463,4.88200649089993e-09
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34408,-0.00533791223190045,0.0268428606649517,-0.0579499191352057,0.0472740946714048,0.842375155937352
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,34499,0.0913824231899977,0.0296965068900026,0.0331772696855926,0.149587576694403,0.00209110970840835
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1598.Average weekly spirits intake,34359,0.0400669368339605,0.028851550146564,-0.016482101453305,0.096615975121226,0.164924679278364
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1608.Average weekly fortified wine intake,34472,0.0595746757479365,0.0475614267408341,-0.0336457206640983,0.152795072159971,0.210365690705373
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X1737.Childhood sunburn occasions,37925,-0.0696148898145488,0.0267465682354796,-0.122038163556089,-0.0171916160730089,0.00925127409933844
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1807.Father's age at death,37227,-0.00026204244450982,0.00203396416349898,-0.00424861220496783,0.00372452731594819,0.897490201462854
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1845.Mother's age,19231,-0.00343011699656204,0.00458112999440445,-0.0124091317855948,0.00554889779247068,0.454017602960492
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1873.Number of full brothers,49651,0.0457537453313995,0.0216459659607792,0.00332765204827239,0.0881798386145267,0.0345432395615646
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X1883.Number of full sisters,49658,0.0271423573382992,0.0216230585268325,-0.0152388373742926,0.069523552050891,0.209393708212073
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20015.Sitting height,50173,-0.0148408672256697,0.0023102395599092,-0.0193689367630917,-0.0103127976882477,1.33967121576357e-10
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20016.Fluid intelligence score,16203,-0.0632285427900558,0.0357946853042134,-0.133386125986314,0.00692904040620249,0.0773438242139756
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20018.Prospective memory result,16886,0.0510528915110517,0.0469570865669735,-0.0409829981602163,0.14308878118232,0.27695317059335
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15998,0.00259112122239477,0.00318938347513491,-0.00366007038886966,0.0088423128336592,0.416562359711721
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15976,0.00148579204312008,0.00319055165623802,-0.00476768920310644,0.0077392732893466,0.641447345617231
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20023.Mean time to correctly identify matches,49954,0.00346641308208293,0.00185615895341813,-0.000171658466616612,0.00710448463078246,0.0618349262795368
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,43948,-0.000808452283601013,0.00395661391729574,-0.00856341556150066,0.00694651099429864,0.838097095345721
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,43080,0.0108160021896942,0.00870506467461447,-0.00624592457255011,0.0278779289519386,0.214060628457317
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,43012,0.0106452544784855,0.0116487603546392,-0.0121863158166073,0.0334768247735783,0.360799222402461
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,43049,0.0136849237518964,0.00985337231093769,-0.00562768597754146,0.0329975334813343,0.164883467422467
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,43076,0.00114984194325374,0.00704302307378452,-0.0126544832813639,0.0149541671678714,0.870314716792205
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#2.Illnesses of father_Stroke,43406,-0.00309301178346712,0.00509164093513562,-0.0130726280163329,0.0068866044493987,0.543543180636762
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43290,0.00106361332898693,0.00642079548950128,-0.0115211458304356,0.0136483724884095,0.868432121555662
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,43099,0.0172664221872994,0.00804327754866963,0.00150159819190688,0.0330312461826918,0.0318235475085334
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43373,0.00779866939197166,0.00587845359530884,-0.00372309965483367,0.019320438438777,0.184630409062304
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,43512,0.00242849830505948,0.00443291890203742,-0.00626002274293388,0.0111170193530528,0.583809536292035
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,43248,0.0271179961330551,0.00614160498476628,0.0150804503629132,0.039155541903197,1.01040642647128e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46100,-0.00604982512157768,0.00452225227900175,-0.0149134395884211,0.00281378934526575,0.1809714140826
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45818,0.00579957765767352,0.00648360903835558,-0.00690829605750342,0.0185074513728505,0.37106000650492
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45673,-0.0372617100208544,0.0140993332303885,-0.0648964031524158,-0.00962701688929301,0.00822517806846673
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45745,0.0042336263932537,0.00725622062535846,-0.00998856603244889,0.0184558188189563,0.559594724719673
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45981,0.00259384037418882,0.00514633697338078,-0.00749298009363751,0.0126806608420152,0.61425197588147
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45772,0.00532869102988692,0.0090936352392758,-0.0124948340390936,0.0231522160988675,0.557891649218835
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45734,0.0131993743282569,0.00815268901016575,-0.00277989613166795,0.0291786447881818,0.105449652452892
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45774,-0.00227054835413248,0.00663600399801156,-0.0152771161902351,0.0107360194819702,0.732235093311574
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45819,0.00647240015980821,0.00762924137176636,-0.00848091292885385,0.0214257132484703,0.39623778942941
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46175,0.00439182771108431,0.00391485449979104,-0.00328128710850612,0.0120649425306747,0.261937686189362
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45885,0.0157642980896145,0.00604825568139518,0.00390971695407993,0.027618879225149,0.00915236170323439
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39531,-0.00627234538714062,0.00634155129866879,-0.0187017859325314,0.00615709515825021,0.32262667683729
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39245,0.0263724556633374,0.0251901922524164,-0.0230003211513988,0.0757452324780735,0.295136708709238
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39236,0.0290606587473084,0.0255018004349903,-0.0209228701052727,0.0790441875998894,0.254479444111061
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39354,-0.00453076206640754,0.00746029599248735,-0.0191529422116827,0.0100914180788677,0.54364428750362
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39267,0.015761163023761,0.0146735059434668,-0.0129989086254338,0.0445212346729559,0.282773769133039
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39314,0.00501082697849967,0.0107270345002242,-0.0160141606419398,0.0260358145989391,0.640415640305036
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39265,0.0117941516253454,0.0126473728450888,-0.0129946991510287,0.0365830024017195,0.351064463492884
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39266,0.0269967879221791,0.0123378537460909,0.00281459457984101,0.0511789812645171,0.0286662444113351
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39294,0.00798469246849934,0.00930077440885179,-0.0102448253728502,0.0262142103098488,0.390622996027099
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39314,0.0248296449492417,0.0114384453950482,0.00241029197494727,0.0472489979235362,0.0299584244996347
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,39665,-0.0038593999794213,0.00472936660902976,-0.0131289585331196,0.00541015857427703,0.414476398154327
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39454,0.0179762361185489,0.00671616392032885,0.00481255483470436,0.0311399174023935,0.0074412319847098
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20127.Neuroticism score,40209,0.0536741567534849,0.0226354505657178,0.00930867364467809,0.0980396398622917,0.0177330515964423
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16203,0.0378791196317752,0.0361538602050549,-0.0329824463701325,0.108740685633683,0.294783317799729
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20161.Pack years of smoking,15384,0.0198512711231694,0.00339296948924608,0.0132010509242471,0.0265014913220917,4.99440333867893e-09
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15384,0.0194049783014295,0.00334748388886637,0.0128439098792514,0.0259660467236075,6.88828438223587e-09
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20191.Fluid intelligence score,12487,-0.0249204425807464,0.0412788192641846,-0.105826928338548,0.0559860431770553,0.5460473474158
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12488,0.0051722242538976,0.0421463244043833,-0.0774345715786937,0.0877790200864889,0.90233029140344
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X20240.Maximum digits remembered correctly,11219,-0.0500593382658963,0.0440399281112249,-0.136377597363897,0.0362589208321045,0.255696097554034
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X20255.Spirometry QC measure,37622,0.0586394777341714,0.0289928079827781,0.00181357408792632,0.115465381380416,0.0431263631824078
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20261.avMSE,11071,0.000570123718469978,0.00377570712794354,-0.00683026225229937,0.00797050968923932,0.879980153921053
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X20262.Myopia diagnosis,11071,-0.0216356322477406,0.0539074433783849,-0.127294221269375,0.0840229567738939,0.688171853659662
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20280.Glucose-lactate,28843,0.0178622824919253,0.00232468341998693,0.0133059029887509,0.0224186619950997,1.5939661028801e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,28906,0.0148408346546624,0.00233821783703265,0.0102579276940784,0.0194237416152464,2.22706932923679e-10
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15769,-0.0214708288831278,0.0124318870284079,-0.0458373274588073,0.00289566969255166,0.0841733961924079
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15766,0.013910049714037,0.0243504342560249,-0.0338168014277719,0.0616369008558458,0.567842120718578
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15764,0.00115235424966208,0.0304395381114765,-0.0585091404488319,0.0608138489481561,0.969802055336584
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15764,-0.0162274837119062,0.0117955525591128,-0.0393467667277673,0.00689179930395483,0.168925113622086
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15764,-0.0158915386224123,0.0205197090748585,-0.056110168409135,0.0243270911643104,0.438674912334824
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15775,-0.00619787310931316,0.0264826353999511,-0.0581038384932173,0.045708092274591,0.814960567289548
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15775,-0.0126043462471428,0.0170328412728557,-0.0459887151419399,0.0207800226476543,0.459309459699305
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15775,0.000152615132303323,0.0191146729087676,-0.0373121437688812,0.0376173740334879,0.993629708804431
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15775,-0.0116979373308587,0.0295321102166047,-0.069580873355404,0.0461849986936866,0.692029914161271
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15775,-0.0272149871014784,0.0341237073097068,-0.0940974534285037,0.039667479225547,0.425150082225646
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15775,-0.00683376383033949,0.019826530217459,-0.0456937630565591,0.0320262353958802,0.73034124596831
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15775,-0.0028057559475518,0.0341326578523667,-0.0697057653381906,0.064094253443087,0.934487518124912
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15775,-0.0136881828437624,0.0255198314647042,-0.0637070525145827,0.0363306868270578,0.591707429700486
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15776,-0.0200485784091005,0.0347781957571751,-0.0882138420931636,0.0481166852749627,0.564305930828926
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15776,-0.0225038984100362,0.0158546687807995,-0.0535790492204032,0.00857125240033085,0.155806222593372
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15776,-0.0121665475385255,0.0235789544910131,-0.0583812983409112,0.0340482032638602,0.605867363317153
PON2,Serum paraoxonase/arylesterase 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15778,0.00582235778065943,0.0393063630064582,-0.0712181137119987,0.0828628292733176,0.882243951301456
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20600.Liking for adding salt to foods,18290,0.046161969274137,0.0343931693323017,-0.0212486426171744,0.113572581165448,0.179552951506736
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20601.Liking for aniseed,18290,0.000137279856420504,0.0342966038522435,-0.0670840636939768,0.0673586234068178,0.996806340159263
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20602.Liking for apple juice,18290,0.058717398999098,0.0345399992822991,-0.00898099959420823,0.126415797592404,0.0891512156645487
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20603.Liking for apples,18290,-0.00120995729845944,0.0351461526951361,-0.0700964165809262,0.0676765019840073,0.972537467386733
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20604.Liking for asparagus,18290,-0.127910938779493,0.0349783341909602,-0.196468473793775,-0.0593534037652114,0.000256038664868676
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20605.Liking for aubergine,18290,-0.173277972246276,0.0344804717399882,-0.240859696856653,-0.105696247635899,5.0714416616524e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20606.Liking for avocados,18290,-0.113419370988883,0.0348513314303643,-0.181727980592397,-0.0451107613853694,0.0011384801339295
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20607.Liking for bacon,18290,0.100299295107122,0.0346781474232101,0.0323301261576302,0.168268464056614,0.00382894924528031
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20608.Liking for baked or steamed fish,18290,-0.134529828563456,0.03496906352189,-0.203069193066361,-0.0659904640605515,0.000119925541691499
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20609.Liking for bananas,18290,-0.0123196754146889,0.0355563869843527,-0.0820101939040203,0.0573708430746424,0.728983922423745
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18290,-0.0225039675602202,0.0344274108975086,-0.0899816929193371,0.0449737577988967,0.513336371395849
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20611.Liking for beef steak,18290,0.0791005073749084,0.0345120366983462,0.0114569154461499,0.146744099303667,0.0219187703705869
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20612.Liking for beetroot,18290,-0.0470395428365415,0.0350818833016462,-0.115800034107768,0.021720948434685,0.179985835193216
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20613.Liking for bell pepper,18290,-0.0950621845057274,0.0346578807926217,-0.162991630859266,-0.0271327381521889,0.00609634878393265
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20614.Liking for bicycling,18290,-0.152893271347166,0.0344643088096115,-0.220443316614005,-0.0853432260803279,9.20622087086648e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20615.Liking for biscuits,18290,0.100813930470914,0.0344939400265446,0.0332058080188861,0.168422052922941,0.00347484912631654
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20616.Liking for bitter foods,18290,-0.0854488469216601,0.0342984317238412,-0.152673773100389,-0.0182239207429314,0.0127352480406241
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20617.Liking for bitter or ale,18290,-0.00915215250667332,0.0352891659794629,-0.0783189178264206,0.060014612813074,0.795370153230687
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20618.Liking for black olives,18290,-0.147286650508787,0.0345810927950498,-0.215065592387085,-0.0795077086304897,2.06216065397539e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20619.Liking for black pepper,18290,-0.00237781769190282,0.0347565461101234,-0.0705006480677446,0.065745012683939,0.94545720776375
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20620.Liking for blue cheese,18290,-0.0415118191776075,0.0344751682411811,-0.109083148930322,0.0260595105751074,0.228563515360751
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20621.Liking for bolognese sauce,18290,0.0754215799048373,0.034624897187641,0.00755678141706097,0.143286378392614,0.0294003934152179
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20622.Liking for broad beans,18290,-0.0592050625102505,0.0343004083593199,-0.126433862894517,0.00802373787401642,0.0843509080616237
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20623.Liking for broccoli,18290,-0.0867093794750536,0.0355265340313837,-0.156341386176566,-0.0170773727735414,0.0146685248146794
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20624.Liking for brown rice,18290,-0.145147770980708,0.0345133695117093,-0.212793975223659,-0.0775015667377583,2.61686507505388e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20625.Liking for brussel sprouts,18290,-0.0454357170594887,0.0347822407553075,-0.113608908939892,0.0227374748209141,0.191470171504477
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20626.Liking for burgers (meat),18290,0.0607121289406324,0.0343444416497273,-0.00660297669283311,0.128027234574098,0.0771206534352562
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20627.Liking for burn of spicy foods,18290,-0.0159664665500075,0.0344027347639023,-0.083395826687256,0.051462893587241,0.642578355667767
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20628.Liking for butter on bread,18290,0.136358221871199,0.0348571885354285,0.0680381323417587,0.204678311400638,9.19000706314768e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20629.Liking for butternut squash,18290,-0.120767602883921,0.034506758361753,-0.188400849272957,-0.0531343564948847,0.000466673447969048
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20630.Liking for cabbage,18290,-0.0156716012259689,0.0349166567937818,-0.0841082485417812,0.0527650460898434,0.653560484298244
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20631.Liking for cake,18290,0.0657444706223779,0.0345957933952941,-0.00206328443239853,0.133552225677154,0.0574015879295589
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20632.Liking for cake icing,18290,0.0419044515827549,0.0341632217290809,-0.0250554630062436,0.108864366171753,0.219990498320848
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20633.Liking for capers,18290,-0.077299623888621,0.0342182768286086,-0.144367446472694,-0.0102318013045481,0.0238941472053738
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20634.Liking for cauliflower,18290,-0.0178468506152283,0.0350852235342195,-0.0866138887422985,0.0509201875118419,0.61098869897623
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20635.Liking for cereal or granola bar,18290,-0.0307463488197151,0.034399431986337,-0.0981692355129356,0.0366765378735054,0.371438561011212
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20636.Liking for cheesecake,18290,0.0295849368437539,0.0343948139635914,-0.0378288985248853,0.0969987722123931,0.38971384333698
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20637.Liking for cherries,18290,-0.0887257363800436,0.0362769732594432,-0.159828603968552,-0.0176228687915349,0.0144630200473095
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20638.Liking for chicken,18290,-0.0153884898990237,0.0361036596187179,-0.0861516627517108,0.0553746829536633,0.669944735488062
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20639.Liking for chilli pepper,18290,-0.0248095730926022,0.0342890439362221,-0.0920160992075974,0.0423969530223931,0.469356051982473
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20640.Liking for chips or french fries,18290,0.113732648187155,0.0347713736251335,0.0455807558818935,0.181884540492417,0.00107415772058271
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20641.Liking for cigarette smoking,18290,-0.0378830799972307,0.0557770450044587,-0.14720608820597,0.0714399282115082,0.497027578166655
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20642.Liking for cod,18290,-0.0745564649621493,0.0357150123277917,-0.144557889124621,-0.00455504079967758,0.0368533021309952
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20643.Liking for coffee with sugar,18290,0.0779093983219465,0.0378498862968202,0.00372362118017887,0.152095175463714,0.0395679495852857
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20644.Liking for coffee without sugar,18290,-0.070014448623893,0.035147701578212,-0.138903943717188,-0.00112495353059748,0.046385209882562
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20645.Liking for coriander,18290,-0.0984320103675734,0.0343699932714933,-0.1657971971797,-0.0310668235554465,0.004189448951407
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20646.Liking for corn flakes,18290,0.165462559798124,0.0344848538499886,0.0978722462521468,0.233052873344102,1.61424649804102e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20647.Liking for cream,18290,0.145372485431442,0.0342517564011258,0.0782390428852354,0.212505927977649,2.20423036103784e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20648.Liking for croissant,18290,0.0728303575600492,0.0344754725000792,0.00525843145989409,0.140402283660204,0.0346548270328454
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20649.Liking for cucumber,18290,0.0471325976534464,0.034647325600437,-0.0207761605234102,0.115041355830303,0.173734990368412
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20650.Liking for curry,18290,-0.0133919308283209,0.0347943568441992,-0.0815888702429514,0.0548050085863095,0.70032486913275
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20651.Liking for dairy products,18290,0.091446112809295,0.0349062623934641,0.0230298385181055,0.159862387100485,0.00880638062098767
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20652.Liking for dark chocolate,18290,-0.144225153707257,0.0347867073342047,-0.212407100082298,-0.0760432073322153,3.39883330683759e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,18290,0.0532708678831575,0.0355211537445886,-0.016350593456236,0.122892329222551,0.133710918150774
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20654.Liking for dried fruit,18290,-0.115486366598477,0.0345455315166878,-0.183195608371185,-0.0477771248257685,0.000830387050219583
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20655.Liking for eggs,18290,0.00113995557904638,0.0355194412133675,-0.0684781491991539,0.0707580603572467,0.974397559392691
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20656.Liking for exercising alone,18290,-0.0934454376506847,0.0344727140644321,-0.161011957216972,-0.0258789180843977,0.00672025818264789
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20657.Liking for exercising with others,18290,-0.155124071348403,0.0344603016799469,-0.222666262641099,-0.0875818800557074,6.78830208984873e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,18290,-0.0678257303470646,0.0347907562715341,-0.136015612639271,0.000364151945142319,0.0512470767586288
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20659.Liking for fatty foods,18290,0.091062783652405,0.0343109324468729,0.0238133560565342,0.158312211248276,0.00796019287831913
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20660.Liking for fresh tomatoes,18290,-0.0336879560911559,0.0369648252402142,-0.106139013561976,0.038763101379664,0.36212212335499
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20661.Liking for fried chicken,18290,0.113314219859279,0.0343800251865139,0.0459293704937121,0.180699069224847,0.000982827628497432
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20662.Liking for fried or battered fish,18290,0.044433766873142,0.0347202468811046,-0.0236179170138229,0.112485450760107,0.200643947113332
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20663.Liking for fruit,18290,-0.0586117990881654,0.0381741488759962,-0.133433130885118,0.0162095327087872,0.124707997332989
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20664.Liking for garlic,18290,-0.0511472141997452,0.0348192424611333,-0.119392929423566,0.0170985010240761,0.14186756040742
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20665.Liking for gherkins,18290,-0.0443039556796319,0.0343664052332553,-0.111662109936812,0.0230541985775486,0.197357166536118
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20666.Liking for globe artichoke,18290,-0.0895895190266982,0.0345129003726819,-0.157234803757155,-0.0219442342962416,0.0094439070058717
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20667.Liking for goat's cheese,18290,-0.134513844502092,0.0343458805396631,-0.201831770359832,-0.0671959186443527,9.01899994002065e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20668.Liking for going to a cafe,18290,0.0230847886502348,0.0346917034095836,-0.0449109500325491,0.0910805273330187,0.505785959706262
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20669.Liking for going to the gym,18290,-0.143965207521392,0.034264057042447,-0.211122759324588,-0.0768076557181958,2.66247165199046e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20670.Liking for going to the pub,18290,-0.0706689995593556,0.0343294010852825,-0.137954625686509,-0.00338337343220194,0.0395509267744522
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20671.Liking for grapefruit,18290,-0.0502384931712848,0.0342387418616178,-0.117346427220056,0.0168694408774861,0.142311781190395
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20672.Liking for green olives,18290,-0.117997192844466,0.0346000645970085,-0.185813319454603,-0.0501810662343293,0.000650277391617087
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20673.Liking for haddock,18290,-0.100338001966225,0.0354000027619608,-0.169722007379668,-0.0309539965527821,0.00459612398518099
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20674.Liking for ham,18290,0.12347713044045,0.034522589868711,0.0558128542977764,0.191141406583123,0.000348851111031447
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20675.Liking for hard cheese,18290,0.000765987748463629,0.035260766417967,-0.0683451144307516,0.0698770899276789,0.982668744108452
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20676.Liking for herring,18290,-0.146831196892445,0.034329235656532,-0.214116498779248,-0.0795458950056423,1.90265439443928e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20677.Liking for honey,18290,-0.00681799177222528,0.0343231998368448,-0.0740914634524412,0.0604554799079906,0.84254585754217
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,18290,-0.06899587306342,0.0343735376584998,-0.13636800687408,-0.00162373925276041,0.0447390242167881
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20679.Liking for ice cream,18290,0.0918800510300701,0.0347655869339688,0.0237395006394912,0.160020601420649,0.00822828409182507
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20680.Liking for jam,18290,0.0592540640145838,0.0344120594566268,-0.00819357252040478,0.126701700549572,0.0851048859231767
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20681.Liking for kiwi fruit,18290,-0.0806284641174809,0.0344991764471652,-0.148246849953925,-0.0130100782810371,0.0194440692330676
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20682.Liking for lager,18290,-0.0143265616213648,0.0346982046244669,-0.0823350426853198,0.0536819194425902,0.679691633536735
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20683.Liking for lamb,18290,0.0205460999962714,0.0345779916588299,-0.0472267636550352,0.0883189636475779,0.552388470196565
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20684.Liking for lemons,18290,-0.0507270427013524,0.0344922090417727,-0.118331772423227,0.016877687020522,0.141394582514556
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20685.Liking for lentils or beans,18290,-0.0874524327881752,0.0347174253681515,-0.155498586509752,-0.0194062790665982,0.011778064499562
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20686.Liking for liver,18290,-0.073386588058615,0.0343796511518745,-0.140770704316289,-0.00600247180094103,0.0328074808917564
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20687.Liking for mackerel,18290,-0.160365079010185,0.0345455276999949,-0.228074313302175,-0.0926558447181954,3.47221699197912e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20688.Liking for marzipan,18290,-0.059225151238779,0.0341185680776179,-0.12609754467091,0.00764724219335205,0.0826049684812062
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20689.Liking for mayonnaise,18290,0.0852098534753069,0.0345893142816509,0.0174147974832712,0.153004909467343,0.0137689614604625
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20690.Liking for melon,18290,0.00348831496658376,0.0355139988597842,-0.0661191227985933,0.0730957527317608,0.921755772661524
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20691.Liking for milk chocolate,18290,0.117091995305087,0.0345461610948447,0.0493815195591912,0.184802471050982,0.000701846792566671
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20692.Liking for mushrooms,18290,-0.0206830779827546,0.0356241820736403,-0.0905064748470897,0.0491403188815805,0.561523330142591
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20694.Liking for orange juice,18290,0.156664653683118,0.0345450850019874,0.0889562870792223,0.224373020287013,5.79483043720988e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20695.Liking for oranges,18290,-0.054464225610108,0.0352587724468054,-0.123571419605847,0.0146429683856305,0.122436168970648
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20696.Liking for pasta,18290,0.00467636334394162,0.0348175853032929,-0.0635661038505125,0.0729188305383958,0.893158619986885
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20697.Liking for pears,18290,-0.00274141130252917,0.0352006819746516,-0.0717347479728463,0.0662519253677879,0.937924764221257
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20698.Liking for pizza,18290,0.0572263151409801,0.0345300073227139,-0.0104524992115391,0.124905129493499,0.0974775662944093
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20699.Liking for plain yogurt,18290,-0.095689435042331,0.0346192261063304,-0.163543118210739,-0.0278357518739233,0.00571451628713767
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20700.Liking for plums,18290,-0.0975731753099563,0.0353490950496775,-0.166857401607324,-0.0282889490125884,0.00578105431024606
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20701.Liking for pollock,18290,-0.122662921809469,0.0342048316157538,-0.189704391776346,-0.0556214518425916,0.000336499397242127
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20702.Liking for pork chop,18290,0.0402804389942414,0.0343537356656693,-0.0270528829104704,0.107613760898953,0.24100367439903
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20703.Liking for porridge,18290,-0.0690858165378313,0.0350681422930877,-0.137819375432283,-0.000352257643379428,0.0488483011389364
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20704.Liking for potato crisps,18290,0.0557803403461505,0.0346648716057853,-0.0121628080011888,0.12372348869349,0.107604848941707
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20705.Liking for potatoes,18290,0.202017954838319,0.0350750843062567,0.133270789598056,0.270765120078582,8.56752571012989e-09
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20706.Liking for prawns,18290,-0.0716830183022635,0.0350235139869384,-0.140329105716663,-0.00303693088786416,0.0407007292137378
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20707.Liking for raw carrots,18290,-0.0583491573754222,0.0348028473031017,-0.126562738089501,0.0098644233386571,0.0936451273655504
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20708.Liking for red meat,18290,0.101355164458492,0.0344953000817918,0.0337443762981802,0.168965952618804,0.00330503441720104
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20709.Liking for red wine,18290,-0.102978927106602,0.0347374033037518,-0.171064237581955,-0.0348936166312484,0.00303569667787416
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18290,0.122705814077845,0.0355259724396292,0.0530749080961722,0.192336720059519,0.000553641764787264
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20711.Liking for roast chicken,18290,-0.00122893498093917,0.0361009213622564,-0.0719867408509618,0.0695288708890834,0.972844308843473
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20712.Liking for salad dressing,18290,0.050526199665434,0.0343781364880285,-0.0168549478511019,0.11790734718197,0.14165510235798
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20713.Liking for salad leaves,18290,-0.0583903730591308,0.035263443014066,-0.1275067213667,0.0107259752484385,0.0977728169921223
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20714.Liking for salami,18290,-0.0295409144858969,0.0343281114570338,-0.0968240129416832,0.0377421839698894,0.389499504828093
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20715.Liking for salmon,18290,-0.151215503587573,0.0360866949882228,-0.22194542576449,-0.0804855814106564,2.79846213105979e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20716.Liking for salty foods,18290,0.0452846878768244,0.0343551350686597,-0.0220513768577486,0.112620752611397,0.187475164387814
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20717.Liking for salty pretzels,18290,-0.00317156632311412,0.0344200208151265,-0.0706348071207621,0.0642916744745339,0.926585380973535
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20718.Liking for sardines,18290,-0.205320357761834,0.0345502340226307,-0.27303881644619,-0.137601899077478,2.8552432003287e-09
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20719.Liking for sausages (meat),18290,0.113791439833884,0.0344100518298435,0.046347738247391,0.181235141420378,0.000945083462838437
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20720.Liking for savoury biscuits,18290,0.0995682652341903,0.0346539405899378,0.0316465416779122,0.167489988790468,0.00406784128942781
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18290,-0.0885669500902071,0.0343875461632376,-0.155966540570153,-0.0211673596102615,0.0100157795199594
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20722.Liking for skimmed milk,18290,-0.0677741577749058,0.0343555091067051,-0.135110955624048,-0.000437359925763811,0.0485413397376287
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20723.Liking for smoked fish,18290,-0.145697617107962,0.0346123471520687,-0.213537817526017,-0.0778574166899076,2.57260647013615e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20724.Liking for soft cheese,18290,-0.00726332548872283,0.0343794866642726,-0.0746471193506971,0.0601204683732515,0.832679598313184
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20725.Liking for soy sauce,18290,0.0272871444990734,0.0346163939208908,-0.0405609875858725,0.0951352765840192,0.430547674914463
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20726.Liking for soya milk,18290,-0.106367681097835,0.0346003409148712,-0.174184349290983,-0.0385510129046879,0.00211393166855879
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20727.Liking for spicy foods,18290,-0.0385249776549922,0.0345490324158029,-0.106241081189966,0.0291911258799816,0.264830282591508
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20728.Liking for spinach,18290,-0.145089328940144,0.0348161923551242,-0.213329065956188,-0.0768495919241007,3.09654382373527e-05
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20729.Liking for spirits,18290,-0.0328895293504105,0.0343545722057013,-0.100224490873585,0.0344454321727641,0.338400657701962
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20730.Liking for strawberries,18290,-0.0213152261002323,0.0375385318573136,-0.0948907485405669,0.0522602963401024,0.570162423006956
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18290,0.120529226285554,0.03525226604122,0.051434784844763,0.189623667726346,0.000629776282120255
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20732.Liking for sweet foods,18290,0.0902806760547624,0.0344704788522537,0.0227185375043452,0.15784281460518,0.00882420892274881
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20733.Liking for taking the stairs,18290,-0.119203675031196,0.034997625788504,-0.187799021576664,-0.0506083284857284,0.000660519321513883
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20734.Liking for tea with sugar,18290,0.129221085547956,0.041814711998497,0.0472642500309017,0.21117792106501,0.00200237533030922
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20735.Liking for tea without sugar,18290,-0.162061714055118,0.0362683017260757,-0.233147585438226,-0.0909758426720093,7.92757638883582e-06
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20736.Liking for tomato ketchup,18290,0.0646690315032584,0.0343731183505949,-0.00270228046390752,0.132040343470424,0.0599356042402729
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20737.Liking for tinned tuna,18290,-0.117407409653792,0.0346784256496048,-0.185377123927018,-0.0494376953805671,0.000711713703197775
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20738.Liking for turnip (white),18290,-0.0416582833685012,0.0344065497309038,-0.109095120841073,0.0257785541040703,0.226000733152471
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20739.Liking for vegetables,18290,-0.0769413109900485,0.0379121894155637,-0.151249202244553,-0.00263341973554364,0.0424258220830049
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20740.Liking for vinegar,18290,0.0192194705110557,0.0346348401843556,-0.0486648162502813,0.0871037572723926,0.578958052077417
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20741.Liking for watching television,18290,0.100510994577862,0.0348114920745227,0.0322804701117974,0.168741519043927,0.00389027384204728
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20742.Liking for whisky,18290,-0.0250318006617143,0.0357331599397919,-0.0950687941437064,0.0450051928202778,0.483611411226175
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20743.Liking for white bread,18290,0.171140523386108,0.0341645642011652,0.104177977551824,0.238103069220391,5.51382196854488e-07
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20744.Liking for white rice,18290,0.0975946073827143,0.034566999732245,0.029843287907514,0.165345926857914,0.00475766265648723
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20745.Liking for white wine,18290,-0.0601741311841189,0.0345119643471491,-0.127817581304531,0.00746931893629323,0.0812503877537519
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18290,-0.118076395997231,0.0347242562433191,-0.186135938234136,-0.0500168537603253,0.000674310732393675
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20747.Liking for whole milk,18290,0.127382350737912,0.0343004213584839,0.0601535248752836,0.194611176600541,0.000204837907767526
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20748.Liking for wholemeal bread,18290,-0.095928136149226,0.0358680264579802,-0.166229468006867,-0.0256268042915848,0.00749130046702939
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X20749.Liking for working up a sweat,18290,-0.194475812100451,0.0345089877961484,-0.262113428180902,-0.12683819602,1.77114126945033e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21001.Body mass index (BMI),50328,0.0268620829561293,0.00764831334712724,0.0118713887957599,0.0418527771164987,0.000444873426646126
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21002.Weight,50367,-0.0213717889046014,0.00429915419233397,-0.029798131121576,-0.0129454466876268,6.67712191514572e-07
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,16763,0.0230405154255518,0.00315297357990397,0.01686068720894,0.0292203436421636,2.84307414466691e-13
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17460,0.0749490572744041,0.0366567165334439,0.00310189286885401,0.146796221679954,0.0409073126322617
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17476,0.0134184920570277,0.0380000277914404,-0.0610615624141955,0.0878985465282509,0.724004276829573
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17478,-0.0630705414738243,0.0374904175260957,-0.136551759824972,0.0104106768773233,0.0925264309977639
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21040.Satisfaction with bowel habits,17405,0.0106942375310044,0.0348105251534184,-0.0575343917696958,0.0789228668317046,0.758685113667752
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17385,0.0515038841213047,0.0370393194226001,-0.0210931819469916,0.124100950189601,0.164389101766494
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21042.Greatest number of times bowels opened per day,17396,0.0458686307548102,0.0373440734652478,-0.0273257532370755,0.119063014746696,0.219362002760761
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21043.Least number of times bowels opened per week,17272,0.0626390416683825,0.0373043283223872,-0.0104774418434964,0.135755525180261,0.0931436395306495
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21044.Average number of times bowels opened per day,17335,0.0997106081572093,0.0417257519544483,0.0179281343264907,0.181493081987928,0.0168743362257278
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17487,0.00272643707674372,0.0378524482483323,-0.0714643614899876,0.076917235643475,0.942580429731904
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17477,-0.0226049461713652,0.0381303589165447,-0.0973404496477927,0.0521305573050624,0.553300402710533
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9831,0.134269888266726,0.0596619334109738,0.0173324987812172,0.251207277752235,0.0244385160083084
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17482,-0.0471449956771938,0.0412559745307636,-0.12800670575749,0.0337167144031028,0.253160776777729
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17480,-0.0901322731588031,0.0568902139980969,-0.201637092595073,0.0213725462774668,0.113139144974557
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17482,-0.0177634737672404,0.044575689092638,-0.105131824388811,0.06960487685433,0.690265509745919
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17481,-0.0171674084991466,0.110462169637823,-0.233673260989279,0.199338443990986,0.876496452167307
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17486,0.0436553987014327,0.0434325926864693,-0.041472482964047,0.128783280366912,0.314848211947983
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17484,-0.16603226210899,0.0430970692345499,-0.250502517808708,-0.0815620064092721,0.000117326737877912
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17084,0.0787023624105775,0.0393369721439659,0.00160189700840425,0.155802827812751,0.0454381199498462
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17478,0.0112993440650331,0.0387226130256025,-0.0645969774651477,0.087195665595214,0.770441321406959
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17485,-0.0522981681732171,0.056369812503229,-0.162783000679546,0.0581866643331116,0.353540191992805
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17486,-0.126815210794319,0.0378561616339958,-0.201013287596951,-0.052617133991687,0.000810052278696903
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17483,-0.0526024825115341,0.0379069272027851,-0.126900059828993,0.0216950948059247,0.165253834778851
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X21100.Water hardness (USGS classification),50067,-0.0106644864406086,0.021796082338458,-0.0533848078239863,0.032055834942769,0.624642398499534
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2139.Age first had sexual intercourse,43659,-0.00254336586711068,0.00195866270645931,-0.00638234477177092,0.00129561303754957,0.194115013489463
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2149.Lifetime number of sexual partners,40507,-0.0545749650535578,0.0247599356229275,-0.103104438874496,-0.00604549123261989,0.0275183994952694
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22032.IPAQ activity group,40510,-0.150057177117956,0.0242061328573272,-0.197501197518318,-0.102613156717595,5.73194885242087e-10
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22033.Summed days activity,41582,-0.013947056388,0.00191195139287707,-0.0176944811180391,-0.010199631657961,3.04720727298734e-13
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22034.Summed minutes activity,40510,-0.00659819212701738,0.00192687210947381,-0.010374861461586,-0.0028215227924487,0.00061699110853805
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22037.MET minutes per week for walking,38776,-0.0027876441015174,0.00196290324994292,-0.00663493447140553,0.00105964626837073,0.155568048099457
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22038.MET minutes per week for moderate activity,40510,-0.00619734152650681,0.00193016486857067,-0.00998046466890532,-0.0024142183841083,0.00132476898367732
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22039.MET minutes per week for vigorous activity,40510,-0.23020243778869,0.0242327178528,-0.277698564780178,-0.182706310797202,2.21675891260062e-21
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X22040.Summed MET minutes per week for all activity,38776,-0.0104714877634589,0.0019707270276058,-0.0143341127375663,-0.00660886278935154,1.08123337976106e-07
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X2217.Age started wearing glasses or contact lenses,42941,0.00299878386728465,0.001914579344527,-0.000753791647988275,0.00675135938255758,0.117288431605703
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X22501.Year ended full time education,12266,-0.00876679581042971,0.00870194036105096,-0.0258225989180896,0.00828900729723017,0.31373703482547
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X22506.Tobacco smoking,12184,0.0547331697327479,0.0899655514986293,-0.121599311204566,0.231065650670061,0.54294736313615
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47260,-0.0267147080835501,0.0574739985202942,-0.139363745183327,0.0859343290162266,0.642066941136191
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23098.Weight,49513,-0.0211809517734759,0.00433201600672519,-0.0296717031466573,-0.0126902004002945,1.01461039052482e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23099.Body fat percentage,49483,0.0531451165569232,0.00415349124329207,0.0450042737200708,0.0612859593937757,1.99745398357049e-37
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23100.Whole body fat mass,49435,0.0338440468653511,0.00401564966976885,0.0259733735126042,0.0417147202180981,3.60845483384522e-17
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23101.Whole body fat-free mass,49507,-0.0407521872257695,0.00361488141241334,-0.0478373547940997,-0.0336670196574394,1.92781527634442e-29
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23102.Whole body water mass,49513,-0.0406185785016797,0.00362038884088528,-0.0477145406298148,-0.0335226163735445,3.55182979304391e-29
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23104.Body mass index (BMI),49513,0.0286023578159159,0.0076765848814006,0.0135562514483707,0.043648464183461,0.000194818623861893
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23105.Basal metabolic rate,49511,-0.0416996816938244,0.00386908003332721,-0.0492830785591457,-0.0341162848285031,4.70292409428323e-27
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23106.Impedance of whole body,49507,0.0399040062330574,0.00296042503281257,0.0341015731687448,0.04570643929737,2.4548726849133e-41
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23107.Impedance of leg (right),49510,0.0422529727562044,0.00241063385895449,0.0375281303926536,0.0469778151197552,1.41897698344906e-68
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23108.Impedance of leg (left),49509,0.0394285019982866,0.00239547416767786,0.034733372629638,0.0441236313669353,1.03867207604423e-60
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23109.Impedance of arm (right),49500,0.0185634895189107,0.00295365632235455,0.0127743231270958,0.0243526559107256,3.30750532684842e-10
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23110.Impedance of arm (left),49508,0.0195862716716084,0.00295661104271822,0.0137913140278807,0.0253812293153361,3.51821310703824e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23111.Leg fat percentage (right),49509,0.0814938879039999,0.00501343836652983,0.0716675487056015,0.0913202271023984,2.92900235589711e-59
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23112.Leg fat mass (right),49508,0.062269645751152,0.00534099816372936,0.0518012893502425,0.0727380021520616,2.27444600396001e-31
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23113.Leg fat-free mass (right),49507,-0.0508760117179298,0.00378163294707716,-0.0582880122942011,-0.0434640111416586,3.47202582826881e-41
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23114.Leg predicted mass (right),49506,-0.0508517198175651,0.00380012039852461,-0.0582999557986733,-0.0434034838364568,9.12009316847081e-41
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23115.Leg fat percentage (left),49503,0.0802057157464309,0.00522937122586571,0.0699561481437341,0.0904552833491277,5.68367141144654e-53
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23116.Leg fat mass (left),49503,0.0589676642399334,0.00557463753216361,0.0480413746768928,0.0698939538029741,4.02594877587216e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23117.Leg fat-free mass (left),49500,-0.0468611335133826,0.00395153028146493,-0.0546061328650539,-0.0391161341617113,2.13881837063659e-32
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23118.Leg predicted mass (left),49499,-0.0471423174093888,0.0039710600385938,-0.0549255950850326,-0.0393590397337449,1.8431890101748e-32
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23119.Arm fat percentage (right),49499,0.0337836420274273,0.00462273309356446,0.024723085164041,0.0428441988908136,2.74914265443502e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23120.Arm fat mass (right),49494,0.0164998804873216,0.00458087604979226,0.00752136342972874,0.0254783975449144,0.000316202964795479
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23121.Arm fat-free mass (right),49495,-0.0251191596818019,0.0036443160808649,-0.0322620192002971,-0.0179763001633067,5.53989436405561e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23122.Arm predicted mass (right),49494,-0.0260573334085529,0.00364882659323806,-0.0332090335312995,-0.0189056332858063,9.37282015856227e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23123.Arm fat percentage (left),49489,0.0394719356743637,0.00473719447631998,0.0301870345007766,0.0487568368479509,8.12659218393068e-17
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23124.Arm fat mass (left),49488,0.0208167207185417,0.00457111498458046,0.0118573353487639,0.0297761060883194,5.27682222803063e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23125.Arm fat-free mass (left),49484,-0.0280959010035935,0.00371459466617564,-0.0353765065492977,-0.0208152954578892,3.98667026992333e-14
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23126.Arm predicted mass (left),49481,-0.0272179138475262,0.00372606839006583,-0.0345210078920552,-0.0199148198029972,2.82003936194873e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23127.Trunk fat percentage,49477,0.0284171204275914,0.00297872627320556,0.0225788169321085,0.0342554239230743,1.49033004597747e-21
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23128.Trunk fat mass,49474,0.0217832327360401,0.00327993951466307,0.0153545512873005,0.0282119141847797,3.14027122778569e-11
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23129.Trunk fat-free mass,49467,-0.0330008621322826,0.00327638443928804,-0.0394225756332872,-0.0265791486312781,7.71976830969454e-24
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X23130.Trunk predicted mass,49462,-0.0331903144994217,0.00327794340983379,-0.0396150835826959,-0.0267655454161474,4.50169901761001e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23400.Total Cholesterol,28916,0.0275241933991365,0.00235774290118908,0.0229030173128059,0.0321453694854671,2.03727620710792e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28916,0.0377585869278247,0.00227973133083505,0.033290313519388,0.0422268603362614,2.48579567238743e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28916,0.0401257410905757,0.00228173909787215,0.0356535324587463,0.0445979497224052,7.26030146731376e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23403.VLDL Cholesterol,28916,0.0506692222256085,0.00227970170558258,0.0462010068826666,0.0551374375685503,1.55683572213866e-108
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,28916,0.0303595686649365,0.00228644754321308,0.0258781314802389,0.0348410058496341,4.0689966512215e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23405.LDL Cholesterol,28916,0.0344651295920678,0.00227803246472796,0.030000185961201,0.0389300732229346,1.63455871123438e-51
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23406.HDL Cholesterol,28916,-0.0306272615034852,0.00265374961063382,-0.0358286107403275,-0.0254259122666429,9.55949764215327e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23407.Total Triglycerides,28916,0.0621415388061828,0.00240600671671685,0.0574257656414178,0.0668573119709478,1.94285252368624e-145
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23408.Triglycerides in VLDL,28916,0.0599888439914934,0.00242669365017784,0.0552325244371449,0.064745163545842,1.57693265383955e-133
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23409.Triglycerides in LDL,28916,0.0620321939826609,0.00233089630850904,0.0574636372179831,0.0666007507473386,3.47128446617664e-154
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23410.Triglycerides in HDL,28916,0.054248527375296,0.00232131915898162,0.049698741823692,0.0587983129269,1.12132886291407e-119
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28916,0.032184441316082,0.00239001640105441,0.0275000091700153,0.0368688734621486,3.29255876604694e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23412.Phospholipids in VLDL,28916,0.0584680184874039,0.00232683986547787,0.0539074123510673,0.0630286246237405,7.50671664106355e-138
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23413.Phospholipids in LDL,28916,0.0360015046770588,0.00227230962998869,0.031547777802281,0.0404552315518367,2.68873161753046e-56
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23414.Phospholipids in HDL,28916,-0.0113075758240763,0.00256354201876743,-0.0163321181808605,-0.00628303346729218,1.03304456690242e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23415.Total Esterified Cholesterol,28916,0.0251795946693241,0.00237058143195093,0.0205332550627002,0.0298259342759479,2.64161710429968e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28916,0.0461034172761086,0.00226987685119523,0.0416544586477659,0.0505523759044512,4.45172894729509e-91
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28916,0.0378189210625199,0.00227166162032242,0.033366464286688,0.0422713778383519,6.07076968400757e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28916,-0.0341898626405698,0.00264389498512308,-0.0393718968114111,-0.0290078284697286,3.80848492650755e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23419.Total Free Cholesterol,28916,0.032762934598726,0.00232721178875535,0.0282015994927656,0.0373242697046865,7.27778066429619e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,28916,0.0556556593366447,0.00230688396834399,0.0511341667586905,0.0601771519145989,2.43427254720511e-127
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23421.Free Cholesterol in LDL,28916,0.0242543370487962,0.00230476957279583,0.0197369886861164,0.0287716854114761,7.49499003021381e-26
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23422.Free Cholesterol in HDL,28916,-0.0166987793238396,0.00265528455859607,-0.0219031370586879,-0.0114944215889913,3.24325266827334e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28916,0.0430326250830972,0.00230096969390989,0.0385227244830338,0.0475425256831606,1.3716488272423e-77
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23424.Total Lipids in VLDL,28916,0.0598974467197504,0.00235605558168268,0.0552795777796523,0.0645153156598484,5.02487220457769e-141
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23425.Total Lipids in LDL,28916,0.0376018442358992,0.0022731120836346,0.0331465445519754,0.042057143919823,3.49609898996632e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23426.Total Lipids in HDL,28916,-0.0153103481192055,0.00259908509711822,-0.0204045549095573,-0.0102161413288538,3.8889129044902e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28916,0.0104290183092676,0.00243953270732008,0.00564753420292023,0.0152105024156149,1.91743883689655e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23428.Concentration of VLDL Particles,28916,0.0550208879217418,0.00229625126644616,0.0505202354395073,0.0595215404039763,1.19012184196995e-125
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23429.Concentration of LDL Particles,28916,0.038185541834978,0.00226632843752157,0.0337435380974357,0.0426275455725203,2.14056380307604e-63
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23430.Concentration of HDL Particles,28916,0.00346465889502041,0.00244869488353972,-0.00133478307671745,0.00826410086675826,0.157108531204466
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28916,0.0542626174534528,0.00252759708685783,0.0493085271632114,0.0592167077436941,1.92244121949671e-101
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,28916,-0.0283744361637718,0.00237419654099519,-0.0330278613841224,-0.0237210109434212,7.65121293751887e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,28916,-0.0491447124748834,0.0027081063030107,-0.0544526008287844,-0.0438368241209824,3.44370781162683e-73
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23434.Phosphoglycerides,28893,0.0283759070164318,0.00240650574307834,0.0236591557599982,0.0330926582728653,5.1240839912782e-32
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28893,0.0612186107897322,0.00256027411945292,0.0562004735156045,0.0662367480638599,3.88452958638819e-125
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23436.Total Cholines,28893,0.0265905776124136,0.002429089909246,0.0218295613902914,0.0313515938345358,7.81474736232046e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23437.Phosphatidylcholines,28893,0.0255519326812511,0.00243837946515409,0.0207727089295491,0.0303311564329531,1.19862876142805e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23438.Sphingomyelins,28892,0.0180586641287729,0.00244932066943856,0.0132579956166734,0.0228593326408725,1.71400625654787e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23439.Apolipoprotein B,28916,0.0397726737182343,0.00226824301343055,0.0353269174119105,0.0442184300245582,1.76683220061073e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23440.Apolipoprotein A1,28916,-0.00541681671999257,0.00253085738352221,-0.0103772971916961,-0.000456336248289033,0.0323381515646555
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28916,0.0383688193815001,0.00231703390713547,0.0338274329235145,0.0429102058394856,2.62373799156014e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23442.Total Fatty Acids,28893,0.0494387043341479,0.00230227673857665,0.0449262419265376,0.0539511667417581,1.70383394114748e-101
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23443.Degree of Unsaturation,28893,-0.0787070341724922,0.00246703286499293,-0.0835424185878783,-0.073871649757106,1.55220703159699e-219
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,28893,-0.0238886203366202,0.00236284406159837,-0.028519794697353,-0.0192574459758874,5.46278125372138e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,28893,0.0353163423061371,0.00231400930662869,0.0307808840651448,0.0398518005471293,2.19530735908108e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28893,0.0241201917551091,0.00232971620836021,0.019553947986723,0.0286864355234951,4.47420068167838e-25
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28893,0.0622924188286675,0.00235053071059868,0.0576853786358941,0.0668994590214409,6.3114648130423e-153
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23448.Saturated Fatty Acids,28893,0.0547333447804341,0.00231011166168418,0.0502055259235331,0.0592611636373351,6.36077329802783e-123
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23449.Linoleic Acid,28893,0.0390212082073117,0.00230298955531884,0.0345073486788868,0.0435350677357366,4.37207129649387e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23450.Docosahexaenoic Acid,28893,-0.0423602074238231,0.00242086885347753,-0.0471051103766391,-0.0376153044710072,3.34310879936599e-68
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28893,-0.0594921846089352,0.00236258805186193,-0.0641228571905846,-0.0548615120272858,2.02327858950351e-138
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28893,-0.048444668893224,0.0024673999800078,-0.0532807728540393,-0.0436085649324087,2.86029743279794e-85
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28893,-0.076627559317527,0.00249128429594804,-0.0815104765375852,-0.0717446420974688,1.89348099247295e-204
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28893,0.0718439820017067,0.00254144221442965,0.0668627552614246,0.0768252087419889,1.92106694591333e-173
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28893,0.0440942989439294,0.00231555449600734,0.039555812131755,0.0486327857561038,2.35234629893655e-80
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28893,-0.0151726414577612,0.00247952565076684,-0.0200325117332642,-0.0103127711822582,9.52720986007305e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28893,-0.075548414228734,0.00240659619042781,-0.0802653427619725,-0.0708314856954955,9.76377011548982e-213
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28893,-0.0778855149496074,0.00253676829338247,-0.082857580804637,-0.0729134490945778,9.92219662502453e-204
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28891,0.0421497329574082,0.00235078548657168,0.0375421934037277,0.0467572725110887,1.67919741552362e-71
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23460.Alanine,28906,0.0122464652064293,0.00231349198534068,0.00771202091516159,0.0167809094976971,1.20873844710171e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23461.Glutamine,28822,-0.0133743966649171,0.00229941561757914,-0.0178812512753722,-0.00886754205446194,6.0751476349718e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23462.Glycine,28881,-0.00841583777577001,0.00242992196964745,-0.013178484836279,-0.00365319071526102,0.00053413035076142
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23463.Histidine,28879,-0.00359068654347225,0.00228560849971444,-0.00807047920291256,0.000889106115968061,0.116194057625398
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28897,0.0190605703352951,0.00242039173763555,0.0143166025295294,0.0238045381410608,3.5265222261934e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23465.Isoleucine,28910,0.0116762016425144,0.00236435281404045,0.00704207012699515,0.0163103331580337,7.91911459260256e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23466.Leucine,28911,0.0181196184576058,0.00241511391161934,0.0133859951908319,0.0228532417243797,6.43658615771852e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23467.Valine,28897,0.0205025183915969,0.00242361978890702,0.0157522236053391,0.0252528131778546,2.81114562199868e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23468.Phenylalanine,28905,0.00514159679241698,0.00230782105367324,0.000618267527217432,0.00966492605761653,0.0258947872638111
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23469.Tyrosine,28883,0.013251036916415,0.00234446742946226,0.00865588075466901,0.0178461930781611,1.60043198937185e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23470.Glucose,28861,0.00112792544292696,0.00232433106715492,-0.00342776344869669,0.00568361433455061,0.627489340382983
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23471.Lactate,28862,0.0318279219540267,0.0022992006579416,0.0273214886644611,0.0363343552435922,1.9303853004018e-43
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23472.Pyruvate,28822,0.00581491891043657,0.00229910455571897,0.00130867398122739,0.0103211638396457,0.0114372397546683
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23473.Citrate,28911,0.0158662130520652,0.0023323554768827,0.0112947963173751,0.0204376297867553,1.04708853459552e-11
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23474.3-Hydroxybutyrate,28449,0.0167267437479919,0.00233667497270697,0.0121468608014863,0.0213066266944976,8.36314330506255e-13
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23475.Acetate,28890,-0.0250516497454933,0.00228988808181129,-0.0295398303858435,-0.0205634691051432,8.40305763091602e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23476.Acetoacetate,28914,0.00408307793627007,0.00230086757232403,-0.000426622505485036,0.00859277837802518,0.0759774735866727
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23477.Acetone,28914,-0.0110828587534189,0.00229907962211111,-0.0155890548127566,-0.0065766626940811,1.4388025295847e-06
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23478.Creatinine,28181,0.0115413153154802,0.00272603164623161,0.00619829328886623,0.0168843373420941,2.3056235670665e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23479.Albumin,28913,0.000564549930929797,0.00232860685803405,-0.00399951951081693,0.00512861937267653,0.808440137026411
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23480.Glycoprotein Acetyls,28916,0.0584645126273313,0.00242605047615775,0.0537094536940621,0.0632195715606004,4.6423015524829e-127
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28916,0.0564429192675799,0.00243607557102201,0.0516682111483767,0.061217627386783,1.09211619569034e-117
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28916,0.0539112614376666,0.00243317545336934,0.0491422375490627,0.0586802853262705,7.11497924043213e-108
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28916,0.0574113135190538,0.00244553309368601,0.0526180686554292,0.0622045583826783,9.69813939401672e-121
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28916,0.0593516099994213,0.00242172091922392,0.0546050369977424,0.0640981830011002,2.66119986568533e-131
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28916,0.0604362027139069,0.00241255805350482,0.0557075889290375,0.0651648164987764,4.98452696597526e-137
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28916,0.0560412554953122,0.00242431247275125,0.0512896030487198,0.0607929079419047,3.6712160657629e-117
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28916,0.0491359408685276,0.0024244862809657,0.0443839477578348,0.0538879339792204,1.08527667448026e-90
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28916,0.0640725222503866,0.00244376938820769,0.0592827342494995,0.0688623102512737,9.19630317058478e-150
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28916,0.0623335045017809,0.00244113285388952,0.0575488841081574,0.0671181248954043,3.07809749919599e-142
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28916,0.0624531286842729,0.00242582971953007,0.057698502433994,0.0672077549345519,1.56351851278996e-144
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28916,0.0607064090159373,0.00237595500652228,0.0560495372031536,0.0653632808287209,2.08056380770613e-142
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28916,0.0583289431890184,0.00234513555022531,0.0537324775105768,0.06292540886746,3.92096529867906e-135
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28916,0.0609942851824324,0.00240658036123748,0.0562773876744069,0.0657111826904579,3.49321573589131e-140
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28916,0.0606850618683688,0.00246613037418105,0.055851446334974,0.0655186774017637,2.42771393750631e-132
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28916,0.062007349589655,0.00241470780273013,0.057274522296304,0.0667401768830061,8.24211770850293e-144
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,28916,0.0597273985486655,0.00241185661918421,0.0550001595750644,0.0644546375222666,5.46410278410105e-134
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,28916,0.0632298939110361,0.00242209215030361,0.058482593296441,0.0679771945256312,1.66848794160832e-148
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,28916,0.0593150821818622,0.00236590369302222,0.0546779109435386,0.0639522534201857,3.04058732296958e-137
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28916,0.0545719267860171,0.00232636714868793,0.0500122471745887,0.0591316063974454,1.4686497110598e-120
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28916,0.0629020878269459,0.0024111088783586,0.058176314425363,0.0676278612285287,2.57790790298452e-148
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,28916,0.0557614567285169,0.00242554139181811,0.0510073956005534,0.0605155178564803,6.55153013412086e-116
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28916,0.0487362486638104,0.00227975470405644,0.0442679294438598,0.0532045678837611,1.29387452691799e-100
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28916,0.0516736934026844,0.002297032651412,0.0471715094059168,0.0561758773994519,4.10701852328666e-111
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28916,0.0477269457035625,0.00227495926403503,0.0432680255460538,0.0521858658610711,5.37081538216714e-97
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28916,0.031729441609692,0.00227792412592193,0.0272647103228851,0.036194172896499,5.84986690530422e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28916,0.0218583630228131,0.00230423237555923,0.017342067566717,0.0263746584789091,2.57405153700545e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28916,0.0426880406920237,0.0022693985776264,0.038240019479876,0.0471360619041715,1.83198612337929e-78
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28916,0.0569709344127824,0.00238052713878719,0.0523051012207595,0.0616367676048053,2.36038237843862e-125
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28916,0.0569316020303116,0.00232392134616465,0.0523767161918289,0.0614864878687944,3.38082970314515e-131
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,28916,0.0567041474025248,0.00231507310052264,0.0521666041255004,0.0612416906795492,3.77768586050315e-131
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,28916,0.049661241611546,0.00228064016048443,0.0451911868969966,0.0541312963260955,2.75611864013217e-104
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,28916,0.0480215668361866,0.00227498593183343,0.0435625944097931,0.0524805392625802,3.66375272311645e-98
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28916,0.0506345805595285,0.00228314846616228,0.0461596095658504,0.0551095515532066,4.51988917242881e-108
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28916,0.0426417450010054,0.00226828990613761,0.0381958967849757,0.0470875932170351,2.25771120180206e-78
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,28916,0.0574419161771592,0.00238681039112299,0.0527637678105581,0.0621200645437602,9.95220567313435e-127
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28916,0.0437850225950423,0.00229901233815897,0.0392789584122507,0.0482910867778339,2.24231951471926e-80
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28916,0.0426114152527362,0.00230724090245585,0.0380892230839228,0.0471336074215497,1.00966505384948e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28916,0.0433658898028524,0.0023033185760927,0.0388513853937107,0.0478803942119941,1.3273987915411e-78
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28916,0.0299727165640887,0.0023435820471356,0.025379295751703,0.0345661373764745,2.37691627829198e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28916,0.0254050859180186,0.00236376470288096,0.0207721071003719,0.0300380647356653,6.82894223557644e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28916,0.0392536289783913,0.00230928589711741,0.0347274286200412,0.0437798293367415,1.74471559701944e-64
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28916,0.0555269544211047,0.0023492532530765,0.0509224180450748,0.0601314907971346,2.38612278543497e-122
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23523.Concentration of IDL Particles,28916,0.0308913034751164,0.00229988169040593,0.0263835353619208,0.0353990715883121,5.23520140627762e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23524.Total Lipids in IDL,28916,0.0269197921338482,0.00235997836738223,0.022294234533779,0.0315453497339174,4.4850604878767e-30
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23525.Phospholipids in IDL,28916,0.0265888961479239,0.00236271711277817,0.0219579706068787,0.0312198216889691,2.56084898515164e-29
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23526.Cholesterol in IDL,28916,0.0212719204190447,0.00237183734913901,0.0166231192147323,0.0259207216233572,3.18168830049195e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28916,0.0214540597549382,0.00237080809811097,0.0168072758826407,0.0261008436272357,1.52734146107519e-19
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23528.Free Cholesterol in IDL,28916,0.0201674651696571,0.00237078970111175,0.0155207173554781,0.0248142129838361,1.87554146913697e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23529.Triglycerides in IDL,28916,0.0548014448332033,0.00232773168208577,0.0502390907363152,0.0593637989300914,2.06838371201014e-121
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,28916,0.0326583009754471,0.00227316743147928,0.0282028928097477,0.0371137091411465,1.209561774054e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23531.Total Lipids in Large LDL,28916,0.0331432969014857,0.00229242995818008,0.0286501341834528,0.0376364596195187,3.27630140240371e-47
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23532.Phospholipids in Large LDL,28916,0.0322340857969521,0.00228982807648135,0.0277460227670486,0.0367221488268555,7.39272903030408e-45
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23533.Cholesterol in Large LDL,28916,0.029619288513508,0.00229987300988095,0.0251115374141414,0.0341270396128747,7.54477941137856e-38
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28916,0.0319058779021147,0.00229110113585941,0.0274153196758303,0.0363964361283991,6.10774173104425e-44
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28916,0.0225978283835577,0.00232878149514399,0.0180334166530755,0.0271622401140399,3.14350771615166e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23536.Triglycerides in Large LDL,28916,0.0601271055785167,0.00232280476478675,0.0555744082395347,0.0646798029174987,4.48812210162173e-146
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28916,0.0447218471226025,0.00226467717108423,0.0402830798672774,0.0491606143779276,3.1214545807768e-86
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,28916,0.0450053997681729,0.00226350670260945,0.0405689266310584,0.0494418729052874,2.19354989640238e-87
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,28916,0.0426683223343735,0.00226328013549382,0.0382322932688057,0.0471043513999414,8.34681718726878e-79
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,28916,0.0427658765318774,0.0022633104461965,0.0383297880573322,0.0472019650064225,3.74624088930817e-79
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28916,0.0471157147607791,0.00226655793719872,0.0426732612038696,0.0515581683176886,2.80942271105724e-95
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28916,0.0286949281647453,0.00227534393959014,0.0242352540431486,0.0331546022863419,2.28286182548687e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,28916,0.0638457054093245,0.00234234038325548,0.0592547182581438,0.0684366925605052,1.5106477456394e-161
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,28916,0.0444191791368642,0.00226377832584309,0.0399821736182117,0.0488561846555167,3.62086082262332e-85
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23545.Total Lipids in Small LDL,28916,0.0415241472850615,0.00226379113034578,0.0370871166695838,0.0459611779005393,1.00258683131961e-74
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23546.Phospholipids in Small LDL,28916,0.0335887696890978,0.00226714380626402,0.0291451678288203,0.0380323715493753,1.76871744502307e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23547.Cholesterol in Small LDL,28916,0.0398849664458943,0.00226323232420299,0.0354490310904564,0.0443209018013321,3.77598556183529e-69
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28916,0.0457529603352047,0.00226378210068182,0.0413159474178683,0.0501899732525411,3.30626215640874e-90
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28916,0.0211445621518263,0.00227879395300429,0.0166781260039379,0.0256109982997147,1.82928198073075e-20
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23550.Triglycerides in Small LDL,28916,0.0620490094552976,0.00237008341207012,0.0574036459676402,0.0666943729429551,2.47514732948865e-149
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28916,-0.0288827964938538,0.0026712922617932,-0.0341185293269685,-0.0236470636607391,3.39399258964268e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28916,-0.0416660688856651,0.00267796007674857,-0.0469148706360923,-0.0364172671352379,2.3022989281378e-54
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28916,-0.0446569240940643,0.00266952032277481,-0.0498891839267029,-0.0394246642614256,1.6019893359142e-62
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28916,-0.0438515911629257,0.00268180672838002,-0.0491079323505505,-0.0385952499753009,7.88143716978093e-60
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28916,-0.0466478116495521,0.00271015047251929,-0.0519597065756899,-0.0413359167234143,4.59092707150293e-66
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28916,-0.0319305863584272,0.00255055193491071,-0.0369296681508522,-0.0269315045660022,7.27428769457378e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28916,0.0427260093370854,0.00230014164943022,0.0382177317042021,0.0472342869699686,1.42074668678975e-76
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,28916,-0.0443626464440856,0.00275813052147328,-0.0497685822661732,-0.038956710621998,5.86956325730445e-58
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23559.Total Lipids in Large HDL,28916,-0.0454664970735008,0.00273820275361268,-0.0508333744705816,-0.0400996196764199,1.24854660962164e-61
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23560.Phospholipids in Large HDL,28916,-0.0424716011975792,0.00270820181412669,-0.0477796767532675,-0.0371635256418909,3.3622019579925e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23561.Cholesterol in Large HDL,28916,-0.0533386273608855,0.0027521896156796,-0.0587329190076175,-0.0479443357141535,3.80966000360591e-83
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28916,-0.0558299496597406,0.00275052267234997,-0.0612209740975465,-0.0504389252219346,5.78272832034036e-91
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28916,-0.0440357816046198,0.00274177000250223,-0.0494096508095242,-0.0386619123997155,8.5114557804419e-58
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23564.Triglycerides in Large HDL,28916,0.0315442326294413,0.00235726458667244,0.0269239940395633,0.0361644712193192,1.02268764647785e-40
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28916,-0.00909386565091029,0.00250812131637732,-0.0140097834310098,-0.00417794787081075,0.000288599055034688
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,28916,-0.00576608833928278,0.00247685927015686,-0.0106207325087902,-0.000911444169775325,0.0199198268820994
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,28916,-0.00128508412914628,0.00244862728829363,-0.00608439361420179,0.00351422535590923,0.599713614062677
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,28916,-0.0194929246664244,0.00252453405176694,-0.0244410114078876,-0.0145448379249612,1.18772486732745e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28916,-0.0215050674067788,0.00251566183124329,-0.0264357645960157,-0.016574370217542,1.30777957637885e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28916,-0.0105635357044764,0.00254760319567551,-0.0155568379680004,-0.00557023344095238,3.38617403174157e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,28916,0.0517921761069991,0.00232467290351723,0.0472358172161053,0.0563485349978929,4.86196608881859e-109
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,28916,0.0298332748226153,0.00227631709876871,0.0253716933090287,0.034294856336202,3.93749089544824e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23573.Total Lipids in Small HDL,28916,0.0350191659811235,0.00228908243059055,0.030532564417166,0.039505767545081,1.2615009366233e-52
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23574.Phospholipids in Small HDL,28916,0.0330078262815012,0.0023006207740477,0.0284986095643678,0.0375170429986347,1.59962499810206e-46
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23575.Cholesterol in Small HDL,28916,0.0230862344591438,0.00227948221993679,0.0186184493080676,0.0275540196102199,4.56040333956081e-24
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28916,0.0183849429838503,0.00227407262999116,0.0139277606290676,0.022842125338633,6.47911234174485e-16
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28916,0.0342597451584399,0.00231281205128416,0.029726633537923,0.0387928567789569,1.83335040229072e-49
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23578.Triglycerides in Small HDL,28916,0.0677597589078483,0.00242703109421354,0.0630027779631897,0.0725167398525068,2.79330755787709e-169
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27682,0.0161865894179745,0.00233851425792489,0.0116031014724417,0.0207700773635073,4.55856543057879e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27682,-0.00763057985531121,0.002370288540129,-0.0122763453939641,-0.00298481431665837,0.00128669205952714
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27682,0.00159994277169452,0.00234996306996546,-0.00300598484543778,0.00620587038882683,0.495980072946123
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27682,-0.020099540623344,0.00239329800291823,-0.0247904047090637,-0.0154086765376242,4.74536770214731e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27682,0.000244188101030155,0.00233746233135602,-0.00433723806842764,0.00482561427048795,0.916799368537556
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28612,0.0248050899817258,0.00228229126277873,0.0203317991066795,0.0292783808567721,1.84293379418336e-27
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28612,-0.0310314394430532,0.00248793020949974,-0.0359077826536727,-0.0261550962324337,1.30087180338373e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28612,-0.0318214959145198,0.00248363963995039,-0.0366894296088225,-0.026953562220217,1.77109801106555e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28612,-0.0191870521554371,0.00242067963516061,-0.0239315842403519,-0.0144425200705223,2.33926159181113e-15
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28612,0.0183829334879093,0.00242981088984504,0.013620504143813,0.0231453628320055,3.97729835880528e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28911,0.0564817984022723,0.00240059498541063,0.0517766322308675,0.0611869645736771,2.9009985931221e-121
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28911,-0.00397704486797166,0.00234826021085139,-0.00857963488124038,0.000625545145297052,0.0903495549117305
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28911,-0.0172073600098456,0.00243183711050991,-0.021973760746445,-0.0124409592732462,1.51898046712809e-12
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28911,0.0274017212302431,0.00229557488682067,0.0229023944520746,0.0319010480084116,9.09225011585757e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28911,-0.0197456399034975,0.00227568932051185,-0.0242059909717008,-0.0152852888352943,4.28136361997008e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28916,-0.000853338360163775,0.00240124457261022,-0.00555977772247981,0.00385310100215226,0.722312494510851
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28916,-0.0277169157371903,0.00249916404081537,-0.0326152772571884,-0.0228185542171922,1.59332816286938e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28916,-0.0318241531955248,0.00251483989799762,-0.0367532393956001,-0.0268950669954495,1.3206388103213e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28916,-0.0148175861754937,0.00244514858252257,-0.0196100773972379,-0.0100250949537495,1.37808880060626e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28916,0.0219162514526744,0.00248139917252385,0.0170527090745277,0.0267797938308212,1.08304011129799e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28916,-0.0233155584546111,0.00243246002985355,-0.028083180113124,-0.0185479367960981,9.94327506136016e-22
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28916,-0.00930360837012485,0.00236665498099134,-0.0139422521328679,-0.00466496460738183,8.47474628700382e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28916,0.0013946071302714,0.00231330796644522,-0.00313947648396123,0.00592869074450403,0.546604749187889
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28916,-0.0230278071859436,0.00244709798066714,-0.0278241192280512,-0.018231495143836,5.30421946102201e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28916,0.0137197748300851,0.00238814174161211,0.0090390170165254,0.0184005326436449,9.28657054833839e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28916,0.0128424458460905,0.00238295563800966,0.00817185279559158,0.0175130388965894,7.12884512932792e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28916,-0.0291523607635258,0.00248450516990271,-0.0340219908965351,-0.0242827306305165,1.01113088143402e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28916,-0.0316123593347174,0.00250858347564378,-0.0365291829469792,-0.0266955357224556,2.57584361217706e-36
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28916,-0.00568494662994886,0.00230705558185129,-0.0102067755703774,-0.00116311768952034,0.0137393793635388
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28916,0.0295059668973184,0.00246764444085301,0.0246693837932465,0.0343425500013903,7.12366959256488e-33
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28916,-0.00975939817420624,0.00227309642234465,-0.0142146671620018,-0.00530412918641072,1.76500426387257e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28916,-0.0181752132302068,0.00239044270000372,-0.0228604809222141,-0.0134899455381996,2.97461521072401e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28916,-0.0137139160427566,0.00237217657045096,-0.0183633821208405,-0.00906444996467276,7.49528395019937e-09
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28916,-0.0173627192331384,0.00232383023977049,-0.0219174265030885,-0.0128080119631882,8.14682246234757e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28916,0.028308573461019,0.00243619829109268,0.0235336248104773,0.0330835221115607,3.82639105200649e-31
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28916,-0.0114962206916824,0.00228707141748347,-0.01597888066995,-0.00701356071341475,5.02199809755593e-07
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28916,-0.0227686118906275,0.00242893323567763,-0.0275293210325557,-0.0180079027486993,7.48214559788844e-21
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28916,0.00465009740250005,0.00227917551599697,0.000182913391145989,0.00911728141385411,0.0413340847426446
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28916,-0.036746139659527,0.00250235797816569,-0.0416507612967318,-0.0318415180223223,1.21170227298346e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28916,0.0264486928573659,0.00239897117298364,0.021746709358318,0.0311506763564139,3.29503321497034e-28
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28916,-0.0307873760456914,0.00228837320018633,-0.0352725875180567,-0.0263021645733262,3.88876733431729e-41
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28916,-0.00236204362009375,0.00231813649272432,-0.00690559114583341,0.00218150390564591,0.3082396490857
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28916,0.0412290828762596,0.00232754399530573,0.0366670966454603,0.0457910691070588,7.71757826557088e-70
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28916,-0.0514746224992176,0.00247277946480381,-0.0563212702502331,-0.0466279747482021,1.54331711752988e-95
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28916,0.0201150626047545,0.00235211935709862,0.0155049086648412,0.0247252165446678,1.2697412751051e-17
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28916,-0.0465629458905066,0.00228847981002976,-0.0510483663181649,-0.0420775254628483,2.17317172918164e-91
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28916,0.0130285363763593,0.00229449670920807,0.00853132282631151,0.0175257499264071,1.37449900522665e-08
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28916,0.0467459303384323,0.00228635998909694,0.0422646647598023,0.0512271959170623,2.96094427134893e-92
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28916,-0.0413464768421797,0.00239162014468978,-0.0460340523257716,-0.0366589013585877,1.25291838935541e-66
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28916,0.0358595879806898,0.00240361041544276,0.031148511566422,0.0405706643949576,3.80948991707319e-50
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28902,-0.0470364798527693,0.00256378829198729,-0.0520615049050644,-0.0420114548004743,9.3728551060036e-75
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28902,0.00818160784462887,0.0024017922553337,0.00347409502417483,0.0128891206650829,0.000659009501628858
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28902,-0.0141525961831905,0.00230497769428213,-0.0186703524639835,-0.00963483990239756,8.35881907875425e-10
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28902,0.0423533464949977,0.00270315425765784,0.0370551641499883,0.047651528840007,4.21461546488131e-55
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28902,0.0685240208941548,0.00250789429808908,0.0636085480699002,0.0734394937184094,2.60239098843732e-162
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28916,0.0310274983416658,0.0025189339333446,0.0260903878323103,0.0359646088510212,8.89254872843799e-35
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28916,-0.0584405725586575,0.00256837685523632,-0.0634745911949207,-0.0534065539223943,1.31000767899225e-113
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28916,-0.0587010128543975,0.00252616792937327,-0.0636523019959691,-0.0537497237128259,2.33663663680556e-118
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28916,-0.0192317529804362,0.00250409123280954,-0.0241397717967428,-0.0143237341641295,1.63938383563534e-14
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28916,0.0647035410097739,0.00246596826878814,0.0598702432029492,0.0695368388165987,5.52389777725249e-150
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28916,0.0372552489762695,0.00254585407114294,0.0322653749968294,0.0422451229557097,2.55041357433588e-48
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28916,-0.054518491683182,0.002494169291749,-0.05940706349501,-0.049629919871354,4.59963964984881e-105
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28916,-0.0540381540667265,0.00242375116981847,-0.0587887063595707,-0.0492876017738823,3.42802127403203e-109
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28916,-0.0229324863823496,0.00266730067161648,-0.0281603956987179,-0.0177045770659813,8.54131367606174e-18
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28916,0.0607575970785063,0.00243163961350396,0.0559915834360386,0.0655236107209741,2.41921122351673e-136
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28916,-0.00952208114788807,0.0023491344268721,-0.0141263846245574,-0.00491777767121875,5.06014561000028e-05
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28916,-0.030589985847907,0.00233799257112931,-0.0351724512873205,-0.0260075204084936,5.2568144769421e-39
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28916,-0.0298104972298232,0.00232295679024963,-0.0343634925387125,-0.0252575019209339,1.35729497284819e-37
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28916,0.00114029326046039,0.00244573515536846,-0.0036533476440618,0.00593393416498258,0.641049077666747
PON2,Serum paraoxonase/arylesterase 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28916,0.0610895472737141,0.00247601613745221,0.0562365556443077,0.0659425389031204,5.03074019273402e-133
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49823,-0.00342727168207313,0.00198842893980415,-0.00732459240408927,0.000470049039943013,0.0847848704018007
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49823,-0.00232327425910438,0.00194028919116952,-0.00612624107379664,0.00147969255558788,0.23116200774429
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46462,-0.000734270411297431,0.00185210415825166,-0.00436439456147069,0.00289585373887583,0.691773427302898
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46462,-0.00250687993648318,0.00201575299443417,-0.00645775580557416,0.0014439959326078,0.213636741669048
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46462,-0.00260893959341088,0.00198895490659664,-0.00650729121034029,0.00128941202351853,0.18962320286212
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46462,-0.00130475219477364,0.00182396531636583,-0.00487972421485067,0.0022702198253034,0.474403641691838
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24009.Traffic intensity on the nearest road,49823,-0.00423732957974226,0.0474762149710161,-0.0972907109229338,0.0888160517634493,0.928882292980468
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24010.Inverse distance to the nearest road,49823,-7.15683181554405e-05,0.00173796648701384,-0.00347798263270256,0.00333484599639168,0.967153086621531
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24011.Traffic intensity on the nearest major road,49823,0.00239039176459324,0.00173870563040416,-0.00101747127099891,0.00579825480018538,0.169196206685139
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24012.Inverse distance to the nearest major road,49823,-0.00314680843847081,0.00176248214082143,-0.00660127343448081,0.000307656557539194,0.0741958440859254
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24013.Total traffic load on major roads,49823,-0.0128422129402445,0.0329931066947765,-0.0775087020620064,0.0518242761815174,0.697100816319477
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24015.Sum of road length of major roads within 100m,49823,-0.0272786206779805,0.032047379455293,-0.0900914844103547,0.0355342430543937,0.394664239049222
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49823,-0.00486065642313027,0.00198550081157197,-0.00875223801381133,-0.0009690748324492,0.0143655703718537
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49823,-0.00534164932333998,0.00198306427806782,-0.0092284553083529,-0.00145484333832706,0.00707014001693361
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49823,-0.00489560254157758,0.00196233253066811,-0.00874177430168708,-0.00104943078146807,0.0126064732634404
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49722,-0.00296103850191726,0.00192652779527287,-0.00673703298065209,0.000814955976817562,0.124304087517582
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24020.Average daytime sound level of noise pollution,49823,-0.00125782995076816,0.001744637727642,-0.00467731989694649,0.00216165999541016,0.470931889611387
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24021.Average evening sound level of noise pollution,49823,-0.00124953961530296,0.00174452902214778,-0.0046688164987126,0.00216973726810669,0.473833025920161
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24022.Average night-time sound level of noise pollution,49823,-0.00126109891473167,0.00174463884068669,-0.00468059104247758,0.00215839321301425,0.469780112861098
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49823,-0.0012496922429555,0.00174458637815453,-0.00466908154413837,0.00216969705822738,0.473793554434336
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49823,-0.00125353362490633,0.00174456600952941,-0.00467288300358398,0.00216581575377131,0.47243017902425
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2405.Number of children fathered,22938,0.0001686961102719,0.0358569069382666,-0.0701108414887306,0.0704482337092744,0.996246244617816
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44458,0.00465630974981005,0.00203927342695724,0.000659333832973855,0.00865328566664624,0.0224163403508351
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44458,0.000210462953801282,0.00184784824858161,-0.00341131961341867,0.00383224552102123,0.909320566603551
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24502.Water percentage, buffer 1000m",44458,-0.00248085217228115,0.00183888552223085,-0.00608506779585361,0.00112336345129131,0.177309675421014
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44458,0.00384852254569682,0.00192014890974128,8.50306826039142e-05,0.00761201440878973,0.0450457690968098
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44458,-0.000544675359170875,0.00186409418874326,-0.00419829996910767,0.00310894925076592,0.770140392071658
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24505.Water percentage, buffer 300m",44458,-0.00205523286224191,0.00184737752180182,-0.00567609280497347,0.00156562708048966,0.26592334642834
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",50068,0.00268938276618757,0.00195516145021599,-0.00114273367623577,0.0065214992086109,0.168973420440185
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",50068,0.00260412417972522,0.00183870096623408,-0.000999729714093588,0.00620797807354402,0.156698367243357
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X24508.Distance (Euclidean) to coast,50068,-0.00310114361446556,0.00174673464751173,-0.00652474352358855,0.000322456294657439,0.0758387965690948
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10984,0.0918309219691686,0.0487886026541667,-0.00379473923299815,0.187456583171335,0.0598324915283977
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2704.Years since last cervical smear test,20685,0.06180458885386,0.0356393199971596,-0.0080484783405728,0.131657656048293,0.0829030849662376
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2714.Age when periods started (menarche),26390,0.0427309438807047,0.0303422984483407,-0.0167399610780431,0.102201848839452,0.159055164363487
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2734.Number of live births,27206,0.0418076649601804,0.0290559381400285,-0.0151419737942755,0.0987573037146363,0.150199386180956
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2744.Birth weight of first child,21589,-0.146194075345869,0.0321869755554315,-0.209280547434514,-0.083107603257223,5.60178874725871e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2754.Age at first live birth,18396,-0.00544453728180387,0.0029996723290211,-0.0113238950466852,0.000434820483077494,0.069533435760131
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2764.Age at last live birth,18344,-0.00185866207905036,0.0028962958723642,-0.0075354019888842,0.00381807783078348,0.521051569423292
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2794.Age started oral contraceptive pill,20856,0.00119097473733705,0.00324159540313669,-0.00516255225281087,0.00754450172748497,0.713321506075422
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2804.Age when last used oral contraceptive pill,18916,-0.00539045483615844,0.00281187366201551,-0.0109017272137088,0.00012081754139197,0.0552487861799532
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2867.Age started smoking in former smokers,12327,-0.0041878311021893,0.00356804460510952,-0.011181198528204,0.00280553632382535,0.240535986381847
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19237,-0.0178977380501534,0.043092451681735,-0.102358943346354,0.0665634672460472,0.677902429219017
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19230,0.0919032063959824,0.0476679280837499,-0.00152593264816743,0.185332345440132,0.0538713039664162
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19266,0.0645893501545738,0.0490472099263139,-0.0315431813010014,0.160721881610149,0.187894115288013
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19213,0.0598363789413449,0.0479111726893051,-0.0340695195296931,0.153742277412383,0.211715999765433
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28739.Difficulty with standing for long periods,19282,0.0521200207212391,0.0412372963655194,-0.0287050801551789,0.132945121597657,0.206279457463456
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28740.Difficulty with taking care of household responsibilities,19329,0.0131342560464913,0.0460635855745307,-0.0771503716795889,0.103418883772571,0.775545178200215
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28741.Difficulty learning a new task,19176,0.112081638756797,0.0525064801221917,0.00916893771730169,0.214994339796293,0.0328043168145191
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28742.Difficulty with joining in community activities,18477,0.00507785879009597,0.0528276520808758,-0.0984643392884207,0.108620056868613,0.923425335270809
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,19204,0.0328531839731993,0.0447611090857813,-0.0548785898349321,0.120584957781331,0.462977723716303
PON2,Serum paraoxonase/arylesterase 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19328,0.0560016196554002,0.0635280653671546,-0.0685133884642229,0.180516627775023,0.378044344244453
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11708,0.0819836412531939,0.0472233456217018,-0.0105741161653416,0.174541398671729,0.082575523709279
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2897.Age stopped smoking,12335,0.0147263426493716,0.00372888408317829,0.0074177298463421,0.022034955452401,7.88286575280295e-05
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17248,0.00223222488932309,0.00614631735863611,-0.00981455713360369,0.0142790069122499,0.716474230802617
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17248,0.00278456238218753,0.00669140215994401,-0.0103305858513027,0.0158997106156778,0.677312493274338
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17248,0.0252986361405778,0.0223024086304185,-0.0184140847750426,0.0690113570561981,0.256665441560476
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17248,-0.0109852864757744,0.0228863137952649,-0.0558424615144936,0.0338718885629448,0.6312379633014
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17248,0.0281105327270757,0.0253752347346759,-0.0216249273528891,0.0778459928070406,0.267966253410025
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17248,-0.00847663076431782,0.0215449254037785,-0.0507046845557237,0.0337514230270881,0.693999558662669
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17248,-0.0158265862037881,0.00964160450889583,-0.0347241310412239,0.00307095863364775,0.100714228409115
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17248,-0.0293741725520754,0.0174322580015248,-0.063541398235064,0.00479305313091324,0.0919976256342781
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,17129,0.127575969376889,0.0496941999130115,0.0301753375473869,0.224976601206392,0.0102601579714333
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29003.Recent feelings of depression,17113,0.118575998336895,0.0482074430698157,0.0240894099200566,0.213062586753734,0.0139150234340582
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17137,0.0871276043528772,0.0388411887808178,0.0109988743424743,0.16325633436328,0.02489823375834
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29005.Recent feelings of tiredness or low energy,17145,0.121280640732603,0.0391037191965218,0.0446373511074207,0.197923930357786,0.0019284804365676
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29006.Recent poor appetite or overeating,17160,0.123002518340304,0.0541552505624623,0.0168582272378774,0.22914680944273,0.0231415020252715
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29007.Recent feelings of inadequacy,17091,0.0563327604400907,0.0523849877988345,-0.0463418156456249,0.159007336525806,0.282228436125005
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29008.Recent trouble concentrating on things,17155,0.0107448202775229,0.051496173590533,-0.0901876799599218,0.111677320514968,0.834721776768242
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17141,0.213596441660433,0.0903084138003573,0.0365919506117329,0.390600932709133,0.0180319660594438
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29010.Recent thoughts of suicide or self-harm,17057,0.214175933829817,0.0996828557903834,0.018797536480665,0.409554331178968,0.0316822779533302
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#0.Substances taken for depression_None of options listed,15821,-0.0205607834206011,0.0120750436844905,-0.0442278690422024,0.00310630220100016,0.0886344803856656
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15821,-0.0284097102218141,0.0232601009030656,-0.0739995079918226,0.0171800875481944,0.221955703262413
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15821,-0.0416255270447095,0.0119565615607161,-0.0650603877037131,-0.0181906663857058,0.00050015382806105
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15821,-0.0509816481750077,0.0344642849870009,-0.118531646749529,0.0165683503995142,0.139090689318857
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15821,-0.0749740275263639,0.0223080954744126,-0.118697894656213,-0.0312501603965151,0.000778887063690722
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15821,-0.055951257620024,0.0238439647390078,-0.102685428508479,-0.00921708673156882,0.0189599714864757
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15821,-0.050677608612305,0.0268246133933202,-0.103253850863213,0.00189863363860258,0.0588805797124088
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15821,-0.0507961994368393,0.0315137224041394,-0.112563095348952,0.0109706964752739,0.107008982574826
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15821,-0.047869827620093,0.0232455061968942,-0.0934310197660056,-0.00230863547418029,0.0394803809400397
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15821,-0.0154888850891048,0.0118184764554475,-0.0386530989417819,0.00767532876357236,0.190023711860482
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15821,0.0012258267261426,0.0182352354627045,-0.0345152347807582,0.0369668882330435,0.946405047535641
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15821,-0.0627724046386112,0.0285358330317299,-0.118702637380802,-0.00684217189642051,0.0278373022679204
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15821,-0.0703288952300946,0.0365122815543803,-0.14189296707668,0.00123517661649084,0.0541009457222641
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15821,-0.0225113941969234,0.0229619791015069,-0.0675168732358769,0.0224940848420302,0.326915105742178
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15821,-0.0764895911057279,0.0371611190547291,-0.149325384452997,-0.00365379775845881,0.0395754790268008
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15821,-0.0685687111224455,0.0358935109269037,-0.138919992539177,0.0017825702942858,0.0561078794439232
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15821,-0.049775818215418,0.0197936998684548,-0.0885714699575894,-0.0109801664732467,0.0119221876794746
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15821,-0.0111531720482077,0.0192608321369552,-0.0489044030366399,0.0265980589402245,0.56255712956605
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15821,-0.0543877256764526,0.0272670143437553,-0.107831073790213,-0.000944377562692292,0.0460999079209292
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29058.Recent feelings or nervousness or anxiety,16883,0.0465862020239877,0.045745945810582,-0.0430758517647531,0.136248255812728,0.308517765514072
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29059.Recent inability to stop or control worrying,16901,0.106438173893327,0.0475770527343469,0.0131871505340071,0.199689197252647,0.0252879267514304
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29060.Recent worrying too much about different things,16892,0.0945714229493886,0.043723134553694,0.00887407922414839,0.180268766674629,0.030558196399622
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29061.Recent trouble relaxing,16893,0.0552368897840525,0.0463903621622717,-0.0356882200540002,0.146161999622105,0.233789093457967
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29062.Recent restlessness,16912,0.115565913521773,0.0660609063737333,-0.0139134629707447,0.24504529001429,0.0802427652064051
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29063.Recent easy annoyance or irritability,16869,0.0893515684600169,0.0469647234014442,-0.0026992894068137,0.181402426326848,0.0571195590363131
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29064.Recent feelings of foreboding,16860,0.126885989190708,0.0537680073826304,0.0215006947207521,0.232271283660663,0.018292237684332
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15821,-0.0360607335620581,0.0125512462174122,-0.0606611761481859,-0.0114602909759302,0.00407032538247994
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15821,-0.021694488759071,0.0210516391498756,-0.0629557014928272,0.0195667239746853,0.30277385603239
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15821,-0.0178637602737783,0.0270341751685083,-0.0708507436040545,0.0351232230564979,0.508760240754485
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15821,-0.0812660898414641,0.0289060499181893,-0.137921947681115,-0.024610232001813,0.00493891536334982
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,15821,-0.0154082372732822,0.0190614200909775,-0.052768620651598,0.0219521461050336,0.41890315338884
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15821,-0.0203722414681228,0.0203652183532391,-0.0602880694404714,0.0195435865042258,0.31715895826395
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15821,-0.0296650021834056,0.0204995413051075,-0.0698441031414162,0.010514098774605,0.147887164284928
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15821,-0.0377236969552796,0.0189344414685421,-0.074835202233622,-0.000612191676937122,0.0463517935187381
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15821,-0.0387589881794308,0.0253143962130035,-0.0883752047569176,0.0108572283980559,0.125763557627024
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29076.Felt loved as a child,16830,-0.0271666939812803,0.0406131814546946,-0.106768529632482,0.0524351416699212,0.503560020819691
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29077.Physically abused by family as a child,16855,0.091169697707534,0.0546025524775877,-0.0158513051485378,0.198190700563606,0.0949979897402662
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29078.Felt hated by family member as a child,16829,0.0533190988841636,0.0552938988550964,-0.0550569428718253,0.161695140640153,0.334916732840976
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29079.Sexually molested as a child,16704,0.0436600915394609,0.0739107092686126,-0.10120489862702,0.188525081705942,0.554720058549407
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29080.Someone to take to doctor when needed as a child,16795,-0.0650068852405668,0.05888582677047,-0.180423105710688,0.0504093352295543,0.269631567728416
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16836,-0.0868075965426007,0.0765692221817569,-0.236883272018844,0.0632680789336428,0.256930706768095
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16733,0.00515702320287369,0.0600159874647613,-0.112474312228059,0.122788358633806,0.931525086935152
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16846,0.0825134713052259,0.0677379253592296,-0.050252862398864,0.215279805009316,0.223192366793801
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16800,-0.0479064342176619,0.0944698869470348,-0.23306741263385,0.137254544198526,0.612085713079926
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16798,-0.0935198167127892,0.0903715467028355,-0.270648048250347,0.0836084148247684,0.300759969213093
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29086.Experienced a violent or sexual assault,16847,-0.0378056756057012,0.0765233852122862,-0.187791510621782,0.11218015941038,0.621283801655745
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29087.Experienced a life-threatening injury or illness,16849,0.0228072888150952,0.0476419742779194,-0.070570980769627,0.116185558399817,0.632142218040321
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29088.Experienced a marital separation or divorce,16855,-0.0316380872470569,0.0444295884368337,-0.118720080583251,0.0554439060891371,0.476415822647323
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29089.Experienced the death of a spouse or partner,16875,-0.0693556391676269,0.0600640566710259,-0.187081190242838,0.0483699119075838,0.248231895760373
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16852,0.0232878803392669,0.0554899398244947,-0.0854724017167428,0.132048162395277,0.674726404060101
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29091.Frequency of drinking alcohol,16859,-0.106331299954097,0.0366250997991518,-0.178116495560434,-0.034546104347759,0.00369807856116074
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,15038,-0.13631425383188,0.0424585310829399,-0.219532974754443,-0.0530955329093181,0.00132770599012219
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,15071,-0.104181149640521,0.0428537716348523,-0.188174542044832,-0.0201877572362108,0.015065287017417
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29104.Ever used cannabis,16846,-0.113068218956806,0.0535050745113059,-0.217938164998966,-0.00819827291464652,0.034596261533117
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29108.Ever thought that life not worth living,16767,0.0197387289685306,0.0465138258747301,-0.0714283697459404,0.110905827683002,0.671306827499901
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29109.Ever contemplated self-harm,16812,-0.0517368900977968,0.062642989794064,-0.174517150094162,0.0710433698985687,0.408872144886796
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29111.Ever self-harmed,16836,-0.0762539125656962,0.101633142321197,-0.275454871515242,0.12294704638385,0.453093033524989
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16831,-0.0480767257002365,0.0661242435580092,-0.177680243073935,0.0815267916734616,0.467195309459491
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,17074,-0.0503521705145189,0.0269188095033795,-0.103113037141143,0.00240869611210496,0.0614287558965907
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,17074,-0.0512638979923566,0.0206478039257074,-0.0917335936867431,-0.0107942022979702,0.0130457970642417
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,17074,-0.0719766572933274,0.0221909352132864,-0.115470890311369,-0.0284824242752861,0.00118291174289163
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,17074,-0.0491479555224024,0.0301973452033098,-0.10833475212089,0.0100388410760847,0.103636933690899
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16815,-0.129271655361774,0.041649213006051,-0.210904112853634,-0.0476391978699137,0.00191356859831494
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X29153.Pain or discomfort today,16841,0.0496227302101654,0.038992873353012,-0.0268033015617382,0.126048761982069,0.203173967182076
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29154.Anxiety or depression today,16841,0.043734724163991,0.0488946746896517,-0.0520988382277263,0.139568286555708,0.371084314499649
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29166.Frequency of confiding in someone close,16433,-0.0339893800973766,0.0383959942387734,-0.109245528805373,0.0412667686106193,0.376044240137315
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16790,0.0149495410249416,0.00622822555596932,0.00274221893524173,0.0271568631146415,0.0163929602898474
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16790,-0.0254084594716851,0.00625351245219326,-0.0376653438779839,-0.0131515750653863,4.86518815800008e-05
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16790,-0.00487845223014091,0.00779099491974279,-0.0201488022728368,0.010391897812555,0.531214912786837
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16790,0.000669703109023879,0.00842952289692659,-0.0158521617689522,0.017191567987,0.936677769252306
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16790,-0.00596371993574421,0.0136462595764291,-0.0327103887055453,0.0207829488340569,0.662100790633213
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16790,-0.00174932770810594,0.00644166002185079,-0.0143749813509335,0.0108763259347216,0.785960058301111
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16785,0.00153391586884739,0.00701681554520209,-0.0122190425997487,0.0152868743374435,0.826959872776092
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16785,-0.0275671669404346,0.0102880698138824,-0.0477317837756441,-0.00740255010522518,0.0073798093244983
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16785,-0.000350935973890049,0.015762961277467,-0.0312463400777255,0.0305444681299454,0.982238166668809
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16785,0.0147825875003838,0.014193010654945,-0.0130357133833083,0.042600888384076,0.297640039419261
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16785,-0.00710457390282261,0.0207813880102854,-0.0478360944029819,0.0336269465973367,0.732451533953723
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16785,0.011108579845735,0.0100856875756105,-0.00865936780246161,0.0308765274939317,0.270729632562043
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29171.Frequency of feeling 'in tune' with people,16505,0.0197940967488486,0.0475019858123538,-0.0733097954433648,0.112897988941062,0.676902981612806
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29172.Freuency of feeling that lacks companionship,16721,-0.0185388254525682,0.043486624806372,-0.103772610073057,0.066694959167921,0.669886753935454
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29173.Frequency of feeling left out,16634,0.0357015149440618,0.0450850591034151,-0.0526652008986317,0.124068230786755,0.428447664412682
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29174.Frequency of feeling isolated from others,16697,-0.0759891139418856,0.0466400982605586,-0.16740370653258,0.0154254786488093,0.103275657932754
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29175.Tendency to bounce back quickly after hard times,16819,-0.0102072025250346,0.0383903926489726,-0.0854523721170208,0.0650379670669517,0.790335594391451
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29176.Ability to make it through stressful events,16819,0.0684688911074677,0.0373618976504102,-0.00476042828733633,0.141698210502272,0.0668818463931984
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29177.Quick recovery from stressful events,16819,-0.00929862067908793,0.0380744782536948,-0.0839245980563297,0.0653273566981538,0.807061963848126
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29178.Hard to snap back when something bad happens,16819,0.0235901193314236,0.037609520689113,-0.0501245412192378,0.097304779882085,0.530511781789548
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29179.Comes through difficult times with little trouble,16819,0.0286070803783377,0.0380001230239394,-0.0458731607485835,0.103087321505259,0.451571357839055
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29180.Tendency to take a long time to get over setbacks,16819,0.0199269164145367,0.0378928130003003,-0.0543429970660519,0.0941968298951254,0.598981388318373
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29181.General happiness,16725,6.61466006262155e-05,0.0391090660741219,-0.0765876229046528,0.0767199161059052,0.998650529358531
PON2,Serum paraoxonase/arylesterase 2,Mental health,X29182.Belief that own life is meaningful,16528,-0.0459008565625969,0.0391219524883685,-0.122579883439799,0.0307781703146054,0.240701980046701
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11227,0.00605824013352861,0.0451681089397097,-0.0824712533883023,0.0945877336553596,0.893304956405748
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2946.Father's age,11021,0.00493242419048315,0.0055272118594355,-0.00590091105401044,0.0157657594349767,0.372203864266043
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X2966.Age high blood pressure diagnosed,12601,0.00494912662111137,0.00436299776284677,-0.00360234899406831,0.013500602236291,0.256673199414956
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48899,0.0267871413749802,0.00184591195411446,0.0231691539449159,0.0304051288050446,1.28536396302178e-47
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48900,0.0433395096022855,0.00205882438797863,0.0393042138018474,0.0473748054027237,6.15303542714323e-98
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30020.Haemoglobin concentration,48900,0.0410060606602476,0.00220359567193923,0.0366870131432468,0.0453251081772485,5.0464843676409e-77
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30030.Haematocrit percentage,48900,0.0398509247034499,0.00215381136323778,0.0356294544315038,0.0440723949753959,3.59091324600561e-76
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30040.Mean corpuscular volume,48900,-0.0133199089663243,0.00182286072633958,-0.0168927159899499,-0.00974710194269874,2.77031156098212e-13
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48899,-0.0121397624577428,0.00182941674323462,-0.0157254192744826,-0.00855410564100294,3.25963463373186e-11
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48899,-0.00194443859626019,0.00178625516048847,-0.00544549871081759,0.00155662151829722,0.276355138863101
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48900,0.00710407626294057,0.00178381893732564,0.00360779114578232,0.0106003613800988,6.82899400402457e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30080.Platelet count,48900,0.0338952098117331,0.00181945331950277,0.0303290813055077,0.0374613383179585,3.44229273077342e-77
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30090.Platelet crit,48900,0.0321483592387149,0.00186029765371003,0.0285021758374432,0.0357945426399865,1.02791291000358e-66
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48900,-0.0133078006742121,0.00175155175775074,-0.0167408421194035,-0.00987475922902062,3.06747854318195e-14
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30110.Platelet distribution width,48900,0.00861741804515544,0.0017714259613908,0.00514542316082948,0.0120894129294814,1.14999008049603e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30120.Lymphocyte count,48823,0.0129648181889629,0.00182079107519243,0.00939606768158579,0.0165335686963401,1.0907072727434e-12
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30130.Monocyte count,48823,0.018178299364016,0.00183519650911451,0.0145813142061516,0.0217752845218804,4.14836694085276e-23
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30140.Neutrophill count,48823,0.0226514787251073,0.00182595860432646,0.0190725998606274,0.0262303575895871,2.76663971358279e-35
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30150.Eosinophill count,48823,0.013976571258927,0.00177786099710222,0.0104919637046066,0.0174611788132473,3.87440333995483e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30160.Basophill count,48823,0.0708704031460719,0.0238839961149677,0.0240577707607351,0.117683035531409,0.00300596989020301
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30170.Nucleated red blood cell count,48823,0.396297151339615,0.108697098358466,0.183250838557022,0.609343464122208,0.000266749546534534
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30180.Lymphocyte percentage,48824,-0.00849612494076593,0.00179192672765201,-0.0120083013269639,-0.00498394855456798,2.12912828100658e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30190.Monocyte percentage,48824,-0.000517955740078621,0.00181603523457724,-0.00407738479985001,0.00304147331969277,0.775482642729024
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30200.Neutrophill percentage,48824,0.00568040161191532,0.00177459471093034,0.00220219597849186,0.00915860724533878,0.00137059567252595
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30210.Eosinophill percentage,48824,0.00538751326182824,0.00176042569332742,0.00193707890290651,0.00883794762074998,0.00221200748583543
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30220.Basophill percentage,48824,-0.00108132641132741,0.0017561346405573,-0.00452335030681971,0.00236069748416489,0.538067474958651
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,48822,0.39524178713084,0.108757183700841,0.182077707077191,0.608405867184488,0.00027916612523193
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30240.Reticulocyte percentage,48049,0.0315491582128464,0.00188508103295331,0.027854399388258,0.0352439170374349,1.0749244240688e-62
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30250.Reticulocyte count,48049,0.0399374624735988,0.00192221168595472,0.0361699275691276,0.04370499737807,1.84759538717397e-95
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30260.Mean reticulocyte volume,48049,-0.00609654867383865,0.00179965928315534,-0.00962388086882311,-0.00256921647885418,0.000705602904092447
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30270.Mean sphered cell volume,48049,-0.0142840169084175,0.00181620817796652,-0.0178437849372319,-0.0107242488796031,3.77518567418333e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30280.Immature reticulocyte fraction,48049,0.016045592566574,0.00188613016986831,0.0123487774336322,0.0197424076995159,1.83318826674677e-17
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,48049,0.031907503844056,0.00192471936731453,0.0281350538841195,0.0356799538039924,1.49762522257547e-61
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30300.High light scatter reticulocyte count,48049,0.0388922735094584,0.00195103954671425,0.0350682359978985,0.0427163110210184,4.6806533724588e-88
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30500.Microalbumin in urine,15893,0.0143467516426464,0.00318349122240891,0.0081071088467249,0.0205863944385678,6.63421554532406e-06
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,49003,0.0099278836398051,0.00190710207264329,0.00618996357742426,0.0136658037021859,1.93999821474518e-07
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30520.Potassium in urine,48903,0.00510999742961932,0.00177807628774888,0.00162496790563152,0.00859502695360712,0.00405623571701452
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30530.Sodium in urine,48889,0.0166627875397567,0.00185572670863444,0.0130255631908332,0.0203000118886802,2.82397017595196e-19
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30600.Albumin,44086,0.00724282005168571,0.0019157805137172,0.00348789024479999,0.0109977498585714,0.000156650418026085
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30610.Alkaline phosphatase,48106,0.0259678096448463,0.00183003950271073,0.0223809322195332,0.0295546870701593,1.3110190613872e-45
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30620.Alanine aminotransferase,48101,0.0510218575473273,0.00192746564090186,0.0472440248911597,0.054799690203495,2.64284537506493e-153
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30630.Apolipoprotein A,43811,-0.0129959523269768,0.0021017125261492,-0.0171153088782293,-0.00887659577572442,6.32456502257718e-10
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30640.Apolipoprotein B,47853,0.0424326754987141,0.0017646493138793,0.0389739628435106,0.0458913881539175,5.23867180154595e-127
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30650.Aspartate aminotransferase,47959,0.034536989256759,0.00183811181781159,0.0309342900938482,0.0381396884196697,1.76765093189797e-78
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30660.Direct bilirubin,40818,-0.00330750996108434,0.00201174974648146,-0.00725053946418799,0.000635519542019319,0.100164052193079
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30670.Urea,48083,-0.0078028002739742,0.00187300981700984,-0.0114738995153135,-0.00413170103263492,3.10646812913265e-05
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30680.Calcium,44083,0.0232789534042001,0.00185277167622835,0.0196475209187925,0.0269103858896076,3.82282595377944e-36
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30690.Cholesterol,48118,0.0347822631587012,0.00179592585104058,0.0312622484906616,0.0383022778267407,3.02640387156729e-83
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30700.Creatinine,48099,-0.00683432454319525,0.0021740406233585,-0.0110954441649779,-0.0025732049214126,0.001669820816369
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30710.C-reactive protein,47974,0.0539129074050984,0.00197458055726598,0.0500427295128571,0.0577830852973397,6.83686119908419e-163
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30720.Cystatin C,48119,0.0491678270651262,0.00206743476378965,0.0451156549280985,0.0532199992021539,2.68208938566777e-124
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30730.Gamma glutamyltransferase,48097,0.0601456855172082,0.00195542989416659,0.0563130429246417,0.0639783281097747,9.45459876034035e-206
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30740.Glucose,44034,0.00556873020840772,0.00190632029578121,0.00183234242867654,0.0093051179881389,0.00348870379646894
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47827,0.0175828161416337,0.00192403454765729,0.0138117084282254,0.021353923855042,6.57222753055286e-20
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30760.HDL cholesterol,44055,-0.0338223983497218,0.00218787794707477,-0.0381106391259883,-0.0295341575734552,9.08756833507598e-54
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30770.IGF-1,47869,-0.0279984761200889,0.00185273497820378,-0.0316298366773684,-0.0243671155628095,1.7760165337396e-51
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30780.LDL direct,48013,0.0383711235719151,0.00177081355839586,0.0349003289974593,0.041841918146371,1.27526876028876e-103
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30790.Lipoprotein A,38460,-0.00662446739173501,0.00198101503370488,-0.0105072568577966,-0.00274167792567346,0.00082665661438148
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30810.Phosphate,43983,0.00406240294972893,0.00192059658278632,0.000298033647467733,0.00782677225199012,0.034420418749656
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30830.SHBG,43667,-0.0171287617831255,0.00220858823890356,-0.0214575947313764,-0.0127999288348745,8.98801401515533e-15
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30840.Total bilirubin,47927,-0.000958736312418981,0.00188749322108718,-0.00465822302574986,0.0027407504009119,0.611496643171954
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30850.Testosterone,43465,0.00477538336135757,0.00310143039212347,-0.00130342020720443,0.0108541869299196,0.123632052049297
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30860.Total protein,44050,0.0250608547520717,0.00188213004834297,0.0213718798573194,0.0287498296468239,2.26242294396325e-40
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30870.Triglycerides,48081,0.0590314509284541,0.00191456949468975,0.0552788947188622,0.062784007138046,9.96941451133115e-207
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30880.Urate,48049,0.0363309497360225,0.00221837140500521,0.0319829417822123,0.0406789576898328,4.04481100444875e-60
PON2,Serum paraoxonase/arylesterase 2,Blood and urine assays,X30890.Vitamin D,45941,-0.0233805584549093,0.00199738347593868,-0.0272954300677491,-0.0194656868420695,1.32330751413006e-31
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3137.Number of measurements made,45735,0.0372627158276697,0.0277642154974658,-0.0171551465473633,0.0916805782027026,0.179566009130068
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3143.Ankle spacing width,28631,0.00240539260758058,0.00316301296983959,-0.00379411281330502,0.00860489802846618,0.446976912469495
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28629,-0.00934746872360342,0.00243527894755715,-0.0141206154608154,-0.00457432198639141,0.000124126856727082
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3146.Speed of sound through heel,28631,-0.00786346811903758,0.00235295218583869,-0.0124752544032814,-0.00325168183479373,0.00083296070680733
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28631,-0.00864751271090764,0.00237747677188671,-0.0133073671838056,-0.00398765823800968,0.000276032373420106
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X3148.Heel bone mineral density (BMD),28610,-0.00912841437125539,0.00238038152423975,-0.0137939621587653,-0.00446286658374549,0.000125908521380126
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3526.Mother's age at death,30061,-7.305465e-06,0.002351634,-0.004616508,0.004601897,0.9975214
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X3581.Age at menopause (last menstrual period),15539,-0.00194183675017518,0.00317387916796425,-0.0081626399193851,0.00427896641903475,0.540667065835928
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9932,0.00113529114821275,0.0039884358609946,-0.00668204313933668,0.00895262543576217,0.775921532338744
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4100.Ankle spacing width (left),16221,-0.00473366340419625,0.00423067361397645,-0.0130257836875901,0.00355845687919759,0.263203147847008
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16217,-0.00673408720442425,0.00326416386992111,-0.0131318483894696,-0.00033632601937888,0.0391251140235099
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4103.Speed of sound through heel (left),16221,-0.00750974471869758,0.00315488262262717,-0.0136933146590468,-0.00132617477834832,0.0173073967070134
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16221,-0.00772139869867176,0.00318827699093417,-0.0139704216009027,-0.0014723757964408,0.0154543545043304
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),16209,-0.00757188960396082,0.00319143875184926,-0.0138271095575854,-0.00131666965033628,0.0176767600430401
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16221,-0.00772149748460509,0.00318828918631666,-0.0139705442897857,-0.00147245067942444,0.0154534312123426
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4119.Ankle spacing width (right),16210,-0.00332367150668235,0.00416044673062833,-0.0114781470987139,0.00483080408534917,0.424375360276521
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16209,-0.00329140801594826,0.00327474536394785,-0.00970990892928604,0.00312709289738951,0.314869384575152
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4122.Speed of sound through heel (right),16210,-0.00363135106369793,0.00316044123489723,-0.0098258158840965,0.00256311375670064,0.250572415810336
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16210,-0.00361166129415838,0.00319581030854767,-0.00987544949891182,0.00265212691059505,0.25844079786433
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),16196,-0.00395485561377823,0.00320021819679113,-0.0102272832794889,0.00231757205193239,0.216547837453859
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16210,-0.0036156874293426,0.00319581107537639,-0.00987947713708033,0.00264810227839512,0.257910529529618
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4194.Pulse rate,16845,0.0324512075184915,0.00303652659741851,0.0264996153875512,0.0384027996494318,1.42564467254317e-26
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4195.Pulse wave reflection index,16845,-0.000940378911608637,0.00312611400341337,-0.00706756235829884,0.00518680453508156,0.763560034677762
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4196.Pulse wave peak to peak time,16834,-0.0228849837162045,0.00310851286866701,-0.0289776689387919,-0.0167922984936172,1.89494046814321e-13
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4198.Position of the pulse wave peak,16845,0.0219112770467934,0.0031366014190235,0.0157635382655073,0.0280590158280794,2.94099154033573e-12
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4199.Position of pulse wave notch,16845,0.0146619100696941,0.00304496705612976,0.00869377463967977,0.0206300454997084,1.48383290748693e-06
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,16845,0.0249618455818989,0.00315184028622138,0.018784238620905,0.0311394525428928,2.52702122214768e-15
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4269.Number of triplets attempted (left),16533,-0.14520375222567,0.116932292966652,-0.374391046440307,0.0839835419889677,0.21433674821117
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4270.Volume level set by participant (left),16356,0.0403685374828147,0.0369283352593425,-0.0320109996254965,0.112748074591126,0.274340165899931
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4276.Number of triplets attempted (right),16533,-0.132216712675926,0.1146942442592,-0.357017431423958,0.0925840060721053,0.249019244435361
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X4277.Volume level set by participant (right),16338,0.0187103916361079,0.036779221401309,-0.0533768823104579,0.0907976655826736,0.610954117643689
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4288.Time to answer,16886,-0.00427309583378448,0.00351988465040033,-0.0111720697485691,0.00262587808100018,0.224769504372558
PON2,Serum paraoxonase/arylesterase 2,Cognitive function,X4290.Duration screen displayed,16886,0.000892145116255648,0.00320994046597844,-0.00539933819706208,0.00718362842957338,0.78106797810257
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X46.Hand grip strength (left),50302,-0.0141674057446817,0.00250653687196341,-0.01908021801373,-0.00925459347563345,1.59278007633268e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X47.Hand grip strength (right),50306,-0.0147671980615728,0.002484497024146,-0.019636812228899,-0.00989758389424669,2.80425966958923e-09
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X48.Waist circumference,50449,0.0575362464279446,0.00386400062187284,0.0499628052090738,0.0651096876468154,4.86700580362043e-50
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X4803.Tinnitus,16577,-0.00507783192458601,0.0436928713233657,-0.0907158597183828,0.0805601958692108,0.90748238135941
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4825.Noisy workplace,16786,0.173007940854648,0.0490191648647339,0.0769303777197693,0.269085503989526,0.00041762811020829
PON2,Serum paraoxonase/arylesterase 2,Working and living environment,X4836.Loud music exposure frequency,16684,0.10897579821068,0.0620530266561993,-0.012648134035471,0.23059973045683,0.0790773792229951
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X49.Hip circumference,50440,-0.0268654155220368,0.00310011788753999,-0.0329416465816152,-0.0207891844624584,4.60854435202708e-18
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X50.Standing height,50395,-0.0146088478224105,0.00246109514367103,-0.0194325943040057,-0.00978510134081526,2.94120427544023e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X5057.Number of older siblings,14814,0.0301353883668507,0.0394083922787026,-0.0471050604994064,0.107375837233108,0.444465561223443
PON2,Serum paraoxonase/arylesterase 2,Physical measures,X51.Seated height,50173,-0.0102503662849387,0.00228817385228367,-0.0147351870354147,-0.00576554553446275,7.49076883976005e-06
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5181.Ever had eye surgery,11383,-0.0521980463098837,0.0888994207497253,-0.226440910979345,0.122044818359578,0.557108955001375
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),11355,0.00148065361057643,0.00371935741057322,-0.00580928691414708,0.00877059413529994,0.690568441683148
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),11352,0.00321765315779696,0.00375514353277581,-0.00414242816644362,0.0105777344820375,0.391537299453974
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5190.Duration at which refractometer first shown (right),11230,0.00109741875018261,0.00377711063771843,-0.00630571809974552,0.00850055560011073,0.771405078107849
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5193.Duration at which refractometer first shown (left),11226,0.00092451551728032,0.00379808749544061,-0.00651973597378328,0.00836876700834392,0.807687552217264
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5199.logMAR, initial (right)",11316,0.0246642504097062,0.0467200029898108,-0.066906955450323,0.116235456269735,0.597567806353462
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5200.Final number of letters displayed (right),11316,-0.0605839516175232,0.305833598865275,-0.660017805393462,0.538849902158415,0.842974697042751
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5201.logMAR, final (right)",11205,0.00377621672351869,0.00378500052109305,-0.0036423842978237,0.0111948177448611,0.318456458329189
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5202.Number of rounds to result (right),11316,0.0282080496622759,0.0437748092649175,-0.0575905764969624,0.114006675821514,0.519335653079573
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5206.logMAR, initial (left)",11308,0.0282688017341318,0.046168137701265,-0.0622207481603477,0.118758351628611,0.540350886675409
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5207.Final number of letters displayed (left),11308,-0.526524422502965,0.27435851010297,-1.06426710230479,0.0112182572988566,0.0549954696433005
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5208.logMAR, final (left)",11198,0.000464910035207351,0.003784925460152,-0.00695354386669057,0.00788336393710528,0.902242325993651
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5209.Number of rounds to result (left),11302,0.0467926989628961,0.0436284601916935,-0.0387190830128232,0.132304480938615,0.283506370611504
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10823,0.00454914445321473,0.00375799604126674,-0.00281652778766809,0.0119148166940975,0.226104350785015
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10823,0.00684239009088781,0.00374416098792442,-0.000496165445444058,0.0141809456272197,0.0676547539771414
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5256.Corneal hysteresis (right),10823,0.00316803430390055,0.00378528898966714,-0.00425113211584704,0.0105872007236481,0.402648579149155
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5257.Corneal resistance factor (right),10823,0.00599562836328162,0.00376663483982357,-0.00138697592277258,0.0133782326493358,0.11146491788472
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10800,0.00534589484663647,0.00374258263403365,-0.00198956711606949,0.0126813568093424,0.153206497603939
PON2,Serum paraoxonase/arylesterase 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10800,0.00997383441946456,0.00372132031561678,0.00268004660085568,0.0172676222380734,0.00736928282589549
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5264.Corneal hysteresis (left),10800,0.00635007139090487,0.00377675096450616,-0.00105236049952721,0.0137525032813369,0.0927223009337553
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X5265.Corneal resistance factor (left),10800,0.0109651167290671,0.00374928047081119,0.00361652700627721,0.0183137064518571,0.00345625846693457
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11312,0.419484017572476,0.207062424670036,0.0136416652192058,0.825326369925747,0.0428003453860072
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50291,-0.00527319701269051,0.0100186725981915,-0.0249097953051459,0.0143634012797649,0.598656475408543
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50291,-0.0197414411921489,0.0109408187565956,-0.0411854459550763,0.00170256357077855,0.0711770701270203
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50291,0.0342553137919506,0.0103818286793968,0.013906929580333,0.0546036980035683,0.000969089089346272
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50291,-0.024950338998172,0.0044522476606554,-0.0336767444130566,-0.0162239335832875,2.10570444465133e-08
PON2,Serum paraoxonase/arylesterase 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50291,0.0158973337559886,0.00409714324346912,0.00786693299878918,0.0239277345131881,0.000104545698085163
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22714,0.00197667435437264,0.0051705104406058,-0.00815752610921473,0.01211087481796,0.702244124400371
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22714,0.00202561579611884,0.014111176234987,-0.0256322896244556,0.0296835212166933,0.88585953731773
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22714,-0.00998316000702994,0.010074269684436,-0.0297287285885246,0.00976240857446469,0.321717530552587
PON2,Serum paraoxonase/arylesterase 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22714,0.0134536384480745,0.00612257821055912,0.00145338515537866,0.0254538917407704,0.0280032962461612
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50442,0.00090077699833758,0.00685601956915411,-0.0125370213572045,0.0143385753538796,0.895471408887862
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50442,0.019970702516601,0.00883765463790423,0.00264889942630876,0.0372925056068933,0.0238423374601796
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50442,0.0111824179248017,0.00678345319167092,-0.00211315033087334,0.0244779861804767,0.0992595036301637
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50442,0.000595464540990498,0.0112013346772305,-0.0213591514263813,0.0225500805083623,0.957604523409834
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50442,0.0457658136890593,0.0269964900219882,-0.00714730675403767,0.0986789341321562,0.0900340808110691
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50442,0.0274424152097348,0.0188046112589901,-0.00941462285788583,0.0642994532773554,0.144476407605209
PON2,Serum paraoxonase/arylesterase 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50442,0.0276567253882546,0.0291147644896261,-0.0294082130114125,0.0847216637879217,0.342156962009853
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50290,-0.00224623530132676,0.00569350114171003,-0.0134054975390784,0.0089130269364249,0.693194270144185
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50290,0.00149262926841361,0.00972429446558579,-0.0175669878841345,0.0205522464209618,0.878008655323448
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50290,0.0139870439625597,0.00510981892622191,0.00397179886716476,0.0240022890579546,0.0061969881630635
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50290,0.0290200315388895,0.00856966333375583,0.0122234914047281,0.0458165716730509,0.000708786044566819
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50290,0.0111882080397788,0.00846844897227787,-0.00540995194588581,0.0277863680254434,0.186452773640632
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50290,0.0274683204323074,0.00477323266308022,0.0181127844126702,0.0368238564519447,8.73204107042358e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15665,-0.0353051220838354,0.0114981349934187,-0.057841466670936,-0.0127687774967347,0.00214060722628809
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15665,-0.0515994084518977,0.00982537981461622,-0.0708571528885455,-0.0323416640152499,1.52719733260216e-07
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15665,-0.00369715044241963,0.0135538102193586,-0.0302626184723625,0.0228683175875232,0.785029217668794
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15665,0.0337477037792954,0.0108220049864705,0.0125365740058132,0.0549588335527777,0.00182144877675087
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,50231,0.0183670954092552,0.014439256311719,-0.00993384696171392,0.0466680377802244,0.203370117412059
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,50231,0.0763310173326915,0.0214574888716822,0.0342743391441945,0.118387695521189,0.000375011638633954
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,50231,0.0639088909318445,0.0379250788894507,-0.0104242636914788,0.138242045555168,0.0919686749794
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,50231,0.0216903539014341,0.0366972899843699,-0.050236334467931,0.0936170422707992,0.554481899966949
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,50231,0.0250585380470756,0.0125128351570014,0.000533381139352911,0.0495836949547982,0.0452227354072678
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,50231,0.00395696506153259,0.0168545886087617,-0.0290780286116404,0.0369919587347056,0.814387598536322
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,50231,0.00514095793944399,0.00774058277723161,-0.01003058430393,0.0203125001828179,0.50659323607651
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16287,-0.0102596523718383,0.0122306727446834,-0.0342317709514177,0.0137124662077411,0.401567988280106
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16287,0.0403563301254526,0.0131121645045968,0.0146564876964428,0.0660561725544623,0.00208896968756632
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16287,-0.0369973143079232,0.0178245514997206,-0.0719334352473757,-0.00206119336847077,0.0379431228442557
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16287,0.0126600291991134,0.00628597637290066,0.000339515508228085,0.0249805428899987,0.0440247431702067
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22869,-0.0234146815089243,0.00591235454000167,-0.0350028964073275,-0.011826466610521,7.50833313687582e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22869,0.00301138879489639,0.00576134877795258,-0.00828085480989066,0.0143036323996834,0.601196345143401
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22869,0.00530153995609349,0.00527638684618236,-0.00504017826242392,0.0156432581746109,0.315019642633055
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22870,-0.00150786823803895,0.0124756901558274,-0.0259602209434606,0.0229444844673827,0.903799411555491
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22870,0.0359602203743633,0.00747801322215938,0.021303314458931,0.0506171262897957,1.52810214770043e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22870,-0.0304598436381788,0.0101323580580342,-0.0503192654319259,-0.0106004218444318,0.0026482656493815
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50290,-0.0388145668052255,0.0118856312852446,-0.0621104041243049,-0.0155187294861462,0.00109277928546511
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50290,-0.0257016044450687,0.00835912779211927,-0.0420854949176224,-0.0093177139725149,0.00210844713290283
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50290,-0.0312196834362147,0.0229973306637364,-0.076294451537138,0.0138550846647087,0.17461734381516
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50290,-0.00748411687779243,0.0085916805496926,-0.0243238107551899,0.00935557699960506,0.383709817026948
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50290,-0.038446975076171,0.0097653589306008,-0.0575870785801486,-0.0193068715721935,8.25910125268024e-05
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50290,-0.0164616865292808,0.0112697981858829,-0.0385504909736112,0.00562711791504972,0.144106661410646
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50290,0.0211648034628987,0.00370640666085699,0.013900246407619,0.0284293605181784,1.13391412125615e-08
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9788,0.000870654866336766,0.0109491851292387,-0.020589747986971,0.0223310577196445,0.936622419938679
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9788,0.027623492230321,0.0136647084080082,0.000840663750624835,0.0544063207100171,0.0432530805405473
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9788,-0.0220652768979604,0.0096969869868445,-0.0410713713921756,-0.00305918240374516,0.0228988426624909
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9788,0.0146113556853775,0.00866346576865532,-0.00236903722118693,0.0315917485919419,0.0917221044213598
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,50516,0.0140805322529827,0.00434227358295571,0.0055696760303895,0.0225913884755759,0.00118494793920982
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,50516,-0.000597523080798041,0.0125362012453455,-0.0251684775216752,0.0239734313600791,0.961984367342813
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,50516,0.00436677029682887,0.00405672524982103,-0.00358441119282036,0.0123179517864781,0.281741286542611
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,50516,0.000491878756374385,0.0039251156879307,-0.00720134799196978,0.00818510550471855,0.900274094665348
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,50516,0.0308532225868798,0.00606771594747869,0.0189604993298216,0.042745945843938,3.69293986370499e-07
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,50516,-0.00831291977697678,0.00542170669204114,-0.0189394648933774,0.00231362533942386,0.125216535845554
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,50516,0.00114767686463174,0.0042225927968651,-0.00712860501722385,0.00942395874648733,0.785781260795486
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,50516,0.0476093222134298,0.012438762735341,0.0232293472521614,0.0719892971746982,0.000129609130018046
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34967,-0.0282055585333278,0.00428011211469596,-0.0365945782781319,-0.0198165387885237,4.46335726731396e-11
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34967,0.0105784047933834,0.00447108393064394,0.00181508028932129,0.0193417292974455,0.0179888210445702
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34967,0.0148211027642009,0.00503987900575656,0.00494293991291808,0.0246992656154838,0.00327616708107218
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34968,-0.0151904124045386,0.00691926676730326,-0.028752175268453,-0.00162864954062424,0.0281429776709135
PON2,Serum paraoxonase/arylesterase 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34968,-0.00656140222867261,0.00451997218069324,-0.0154205477028314,0.00229774324548615,0.146608870550409
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,50054,0.00250505648969276,0.00437298666938917,-0.00606599738231001,0.0110761103616955,0.566750217093311
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,50054,-0.0117288851201402,0.0034819645584363,-0.0185535356546753,-0.00490423458560503,0.000756442407994503
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,50054,0.00245728163456437,0.00386404461902639,-0.00511624581872735,0.0100308090878561,0.524821626556143
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,50054,-0.0453534016658117,0.00698565102062419,-0.0590452776662352,-0.0316615256653883,8.52872844280232e-11
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),50089,-0.0221863287950863,0.00384682466499598,-0.0297261051384784,-0.0146465524516942,8.09571086097187e-09
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,50089,-0.0416729280162107,0.00600507922786145,-0.0534428833028191,-0.0299029727296023,3.97940002056049e-12
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50290,-0.0311490088362049,0.00378550347888953,-0.0385685956548284,-0.0237294220175815,1.94071975140876e-16
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50290,-0.0265527552049804,0.00448649786296588,-0.0353462910163935,-0.0177592193935672,3.2724889738531e-09
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50290,-0.0125312121991086,0.00677166836393075,-0.0258036821924129,0.000741257794195697,0.0642422792635884
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50290,-0.039435405964584,0.00856050547962124,-0.0562139967046417,-0.0226568152245264,4.10174787023961e-06
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50290,-0.0127695576196848,0.00934572918854731,-0.0310871868292375,0.00554807158986796,0.171834555595071
PON2,Serum paraoxonase/arylesterase 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50290,-0.06021140879688,0.011164595748541,-0.0820940164640204,-0.0383288011297395,6.95769646535209e-08
PON2,Serum paraoxonase/arylesterase 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28631,-0.00864703461262556,0.00237747918560708,-0.0133068938164154,-0.00398717540883567,0.000276251741086017
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X864.Number of days or week walked 10+ minutes,49422,-0.0546977961658887,0.0214801605748442,-0.0967989108925834,-0.0125966814391941,0.0108860081550191
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X874.Duration of walks,42837,0.00326253145827017,0.00186368230945544,-0.000390285868262501,0.00691534878480284,0.0800248438243236
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47783,-0.101089069779297,0.0208271257440053,-0.141910236237547,-0.0602679033210466,1.21547690999352e-06
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X894.Duration of moderate activity,37019,-0.00364899286348012,0.025289173658575,-0.0532157732342871,0.0459177875073269,0.885271698381343
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,10543,-0.00395578165809183,0.00394268181040826,-0.011683438006492,0.00377187469030836,0.315728305394
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47689,-0.195702889173105,0.0214500164538867,-0.237744921422723,-0.153660856923487,7.53716869472941e-20
PON2,Serum paraoxonase/arylesterase 2,Physical activities,X914.Duration of vigorous activity,26718,-0.00445093769534228,0.00234815161660225,-0.00905331486388269,0.000151439473198142,0.0580360602612032
